![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 267
Zeitschriftenartikel
Schindler, Florian 
ORCID: https://orcid.org/0000-0003-4512-4114; Schinkoethe, Timo; Mahner, Sven ORCID: https://orcid.org/0000-0002-2224-5709; Kolben, Thomas; Wuerstlein, Rachel; Culmsee, Carsten; Harbeck, Nadia ORCID: https://orcid.org/0000-0002-9744-7372 und Eggersmann, Tanja K.
(2023):
Clinical relevance of potential self-medication drug interactions in antineoplastic and immune-modulating therapy among online pharmacy customers.
In: Therapeutic Advances in Drug Safety, Bd. 14
[PDF, 355kB]
ORCID: https://orcid.org/0000-0003-4512-4114; Schinkoethe, Timo; Mahner, Sven ORCID: https://orcid.org/0000-0002-2224-5709; Kolben, Thomas; Wuerstlein, Rachel; Culmsee, Carsten; Harbeck, Nadia ORCID: https://orcid.org/0000-0002-9744-7372 und Eggersmann, Tanja K.
(2023):
Clinical relevance of potential self-medication drug interactions in antineoplastic and immune-modulating therapy among online pharmacy customers.
In: Therapeutic Advances in Drug Safety, Bd. 14
[PDF, 355kB]
Stefan, Alexandra; Petkovic, Marija; König, Alexander; Koch, Julian; Hagemann, Friederike; Wuerstlein, Rachel; Harbeck, Nadia; Mahner, Sven und Kaltofen, Till
(22. März 2022):
Increased risk for thromboembolic events from combination of a gynecologic malignancy with severe acute respiratory syndrome coronavirus 2 infection: a case report.
In: Journal of Medical Case Reports, Bd. 16
[PDF, 1MB]
Harbeck, Nadia; Burstein, Harold J.; Hurvitz, Sara A.; Johnston, Stephen und Vidal, Gregory A.
(2022):
A look at current and potential treatment approaches for hormone receptor-positive, HER2-negative early breast cancer.
In: Cancer, Bd. 128: S. 2209-2223
[PDF, 354kB]
Harbeck, Nadia ORCID: https://orcid.org/0000-0002-9744-7372
(2022):
Neoadjuvant and adjuvant treatment of patients with HER2-positive early breast cancer.
In: Breast, Bd. 62, Nr. Suppl. 1:
S12-S16
ORCID: https://orcid.org/0000-0002-9744-7372
(2022):
Neoadjuvant and adjuvant treatment of patients with HER2-positive early breast cancer.
In: Breast, Bd. 62, Nr. Suppl. 1:
S12-S16
Aapro, Matti; Cardoso, Fatima; Curigliano, Giuseppe; Eniu, Alexandru; Gligorov, Joseph; Harbeck, Nadia; Mueller, Andreas; Pagani, Olivia; Paluch-Shimon, Shani; Senkus, Elzbieta; Thurlimann, Beat und Zaman, Khalil
(2022):
Current challenges and unmet needs in treating patients with human epidermal growth factor receptor 2-positive advanced breast cancer.
In: Breast, Bd. 66: S. 145-156
Schettini, Francesco; Venturini, Sergio; Giuliano, Mario; Lambertini, Matteo; Pinato, David J.; Onesti, Concetta Elisa; De Placido, Pietro; Harbeck, Nadia; Lueftner, Diana; Denys, Hannelore; Dam, Peter van; Arpino, Grazia; Zaman, Khalil; Mustacchi, Giorgio; Gligorov, Joseph; Awada, Ahmad; Campone, Mario; Wildiers, Hans; Gennari, Alessandra; Tjan-Heijnen, Vivianne; Bartsch, Rupert; Cortes, Javier; Paris, Ida; Martin, Miguel; De Placido, Sabino; Del Mastro, Lucia; Jerusalem, Guy; Curigliano, Giuseppe; Prat, Aleix und Generali, Daniele
(2022):
Multiple Bayesian network meta-analyses to establish therapeutic algorithms for metastatic triple negative breast cancer.
In: Cancer Treatment Reviews, Bd. 111, 102468
Corti, Chiara; Antonarelli, Gabriele; Valenza, Carmine; Nicolo, Eleonora; Rugo, Hope; Cortes, Javier; Harbeck, Nadia; Carey, Lisa A.; Criscitiello, Carmen und Curigliano, Giuseppe
(2022):
Histology-agnostic approvals for antibody-drug conjugates in solid tumours: is the time ripe?
In: European Journal of Cancer, Bd. 171: S. 25-42
Nitz, Ulrike; Gluz, Oleg; Graeser, Monika; Christgen, Matthias; Kuemmel, Sherko; Grischke, Eva-Maria; Braun, Michael; Augustin, Doris; Potenberg, Jochem; Krauss, Katja; Schumacher, Claudia; Forstbauer, Helmut; Reimer, Toralf; Stefek, Andrea; Fischer, Hans Holger; Pelz, Enrico; Eulenburg, Christine zu; Kates, Ronald; Würstlein, Rachel; Kreipe, Hans Heinrich und Harbeck, Nadia
(2022):
De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR-): survival outcomes from a multicentre, open-label, randomised, phase 2 trial.
In: Lancet Oncology, Bd. 23, Nr. 5: S. 625-635
Grote, Isabel; Bartels, Stephan; Christgen, Henriette; Radner, Martin; Gronewold, Malte; Kandt, Leonie; Raap, Mieke; Lehmann, Ulrich; Gluz, Oleg; Graeser, Monika; Kuemmel, Sherko; Nitz, Ulrike; Harbeck, Nadia; Kreipe, Hans und Christgen, Matthias
(2022):
ERBB2 mutation is associated with sustained tumor cell proliferation after short-term preoperative endocrine therapy in early lobular breast cancer.
In: Modern Pathology, Bd. 35, Nr. 12: S. 1804-1811
de Gregorio, Amelie; Janni, Wolfgang; Friedl, Thomas W. P.; Nitz, Ulrike; Rack, Brigitte; Schneeweiss, Andreas; Kates, Ronald; Fehm, Tanja; Kreipe, Hans; Christgen, Matthias; Kuemmel, Sherko; Trapp, Elisabeth; Wuerstlein, Rachel; Haertkopf, Andreas; Clemens, Michael; Reimer, Toralf; Haeberle, Lothar; Fasching, Peter A.; Gluz, Oleg und Harbeck, Nadia
(2022):
The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer-a pooled analysis of the randomised clinical trials PlanB and SUCCESS C.
In: British Journal of Cancer, Bd. 126, Nr. 12: S. 1715-1724
Barrett, James E.; Herzog, Chiara; Jones, Allison; Leavy, Olivia C.; Evans, Iona; Knapp, Susanne; Reisel, Daniel; Nazarenko, Tatiana; Kim, Yoo-Na; Franchi, Dorella; Ryan, Andy; Franks, Joanna; Bjorge, Line; Zikan, Michal; Cibula, David; Harbeck, Nadia; Colombo, Nicoletta; Dudbridge, Frank; Jones, Louise; Sundstrom, Karin; Dillner, Joakim; Radestad, Angelique Floter; Gemzell-Danielsson, Kristina; Pashayan, Nora und Widschwendter, Martin
(2022):
The WID-BC-index identifies women with primary poor prognostic breast cancer based on DNA methylation in cervical samples.
In: Nature Communications, Bd. 13, Nr. 1, 449
Bruzas, Simona; Gluz, Oleg; Harbeck, Nadia; Schmid, Peter; Cortes, Javier; Blohmer, Jens; Seiberling, Christine; Chiari, Ouafaa; Harrach, Hakima; Ataseven, Beyhan; Shenoy, Satyendra; Dyson, Mark H.; Traut, Eugen; Theuerkauf, Ingo; Gebauer, Daniel; Kuemmel, Sherko und Reinisch, Mattea
(2022):
Gene signatures in patients with early breast cancer and relapse despite pathologic complete response.
In: Npj Breast Cancer, Bd. 8, Nr. 1, 42
Barrios, Carlos H.; Saji, Shigehira; Harbeck, Nadia; Zhang, Hong; Jung, Kyung H.; Patel, Sheetal; Patel, Shilpen; Anh Nguyen, Duc; Liste-Hermoso, Mario; Chui, Stephen Y. und Mittendorf, Elizabeth A.
(2022):
Patient-reported outcomes from a randomized trial of neoadjuvant atezolizumab-chemotherapy in early triple-negative breast cancer.
In: Npj Breast Cancer, Bd. 8, Nr. 1, 108
Zhu, Zhou; Turner, Nicholas C.; Loi, Sherene; Andre, Fabrice; Martin, Miguel; Dieras, Veronique; Gelmon, Karen A.; Harbeck, Nadia; Zhang, Cathy; Cao, Joan Q.; Yan, Zhengming; Lu, Dongrui R.; Wei, Ping; VanArsdale, Todd L.; Rejto, Paul A.; Huang, Xin; Rugo, Hope S.; Loibl, Sibylle; Cristofanilli, Massimo; Finn, Richard S. und Liu, Yuan
(2022):
Comparative biomarker analysis of PALOMA-2/3 trials for palbociclib.
In: Npj Precision Oncology, Bd. 6, Nr. 1, 56
Pichler, Theresia; Frank, Tamara; Maier, Sabrina; Batenhorst, Ineke; Albawi-Daltrozzo, Tanja; Harbeck, Nadia; Algul, Hana; Heinemann, Volker; Hermelink, Kerstin; Mumm, Friederike und Dinkel, Andreas
(2022):
Die Auswirkungen der COVID-19-Pandemie aus der Sicht ambulanter Krebspatienten.
In: Deutsche Medizinische Wochenschrift, Bd. 147, Nr. 10, E41-E49
Welslau, Manfred; Mueller, Volkmar; Lueftner, Diana; Schuetz, Florian; Stickeler, Elmar; Fasching, Peter A.; Janni, Wolfgang; Thomssen, Christoph; Witzel, Isabell; Fehm, Tanja N.; Belleville, Erik; Bader, Simon; Seitz, Katharina; Untch, Michael; Thill, Marc; Tesch, Hans; Ditsch, Nina; Lux, Michael P.; Aktas, Bahriye; Banys-Paluchowski, Maggie; Schneeweiss, Andreas; Harbeck, Nadia; Wuerstlein, Rachel; Hartkopf, Andreas D.; Woeckel, Achim; Seliger, Barbara; Massa, Chiara und Kolberg, Hans-Christian
(2022):
Update Breast Cancer 2022 Part 1-Early Stage Breast Cancer.
In: Geburtshilfe und Frauenheilkunde, Bd. 82, Nr. 6: S. 580-589
Müller, Volkmar; Welslau, Manfred; Lüftner, Diana; Schütz, Florian; Stickeler, Elmar; Fasching, Peter A.; Janni, Wolfgang; Thomssen, Christoph; Witzel, Isabell; Fehm, Tanja N.; Belleville, Erik; Bader, Simon; Seitz, Katharina; Untch, Michael; Thill, Marc; Tesch, Hans; Ditsch, Nina; Lux, Michael P.; Aktas, Bahriye; Banys-Paluchowski, Maggie; Schneeweiss, Andreas; Harbeck, Nadia; Würstlein, Rachel; Hartkopf, Andreas D.; Kolberg, Hans-Christian und Wöckel, Achim
(2022):
Update Breast Cancer 2022 Part 2-Advanced Stage Breast Cancer.
In: Geburtshilfe und Frauenheilkunde, Bd. 82, Nr. 6: S. 590-600
Banys-Paluchowski, Maggie; Thill, Marc; Kuhn, Thorsten; Ditsch, Nina; Heil, Jörg; Woeckel, Achim; Fallenberg, Eva; Friedrich, Michael; Kuemmel, Sherko; Mueller, Volkmar; Janni, Wolfgang; Albert, Ute-Susann; Bauerfeind, Ingo; Blohmer, Jens-Uwe; Budach, Wilfried; Dall, Peter; Fasching, Peter; Fehm, Tanja; Gluz, Oleg; Harbeck, Nadia; Huober, Jens; Jackisch, Christian; Kolberg-Liedtke, Cornelia; Kreipe, Hans H.; Krug, David; Loibl, Sibylle; Lueftner, Diana; Lux, Michael Patrick; Maass, Nicolai; Mundhenke, Christoph; Nitz, Ulrike; Park-Simon, Tjoung Won; Reimer, Toralf; Rhiem, Kerstin; Rody, Achim; Schmidt, Marcus; Schneeweiss, Andreas; Schuetz, Florian; Sinn, H. Peter; Solbach, Christine; Solomayer, Erich-Franz; Stickeler, Elmar; Thomssen, Christoph; Untch, Michael; Witzel, Isabell und Gerber, Bernd
(2022):
AGO Recommendations for the Surgical Therapy of Breast Cancer: Update 2022.
In: Geburtshilfe und Frauenheilkunde, Bd. 82, Nr. 10: S. 1031-1043
Fehm, Tanja N.; Welslau, Manfred; Mueller, Volkmar; Lueftner, Diana; Schuetz, Florian; Fasching, Peter A.; Janni, Wolfgang; Thomssen, Christoph; Witzel, Isabell; Belleville, Erik; Untch, Michael; Thill, Marc; Tesch, Hans; Ditsch, Nina; Lux, Michael P.; Aktas, Bahriye; Banys-Paluchowski, Maggie; Schneeweiss, Andreas; Kolberg-Liedtke, Cornelia; Hartkopf, Andreas D.; Woeckel, Achim; Kolberg, Hans-Christian; Harbeck, Nadia und Stickeler, Elmar
(2022):
Update Breast Cancer 2022 Part 3-Early-Stage Breast Cancer.
In: Geburtshilfe und Frauenheilkunde, Bd. 82, Nr. 9: S. 912-921
Aktas, Bahriye; Fehm, Tanja N.; Welslau, Manfred; Mueller, Volkmar; Lueftner, Diana; Schuetz, Florian; Fasching, Peter A.; Janni, Wolfgang; Thomssen, Christoph; Witzel, Isabell; Belleville, Erik; Untch, Michael; Thill, Marc; Tesch, Hans; Ditsch, Nina; Lux, Michael P.; Banys-Paluchowski, Maggie; Kolberg-Liedtke, Cornelia; Hartkopf, Andreas D.; Woeckel, Achim; Kolberg, Hans-Christian; Stickeler, Elmar; Harbeck, Nadia und Schneeweiss, Andreas
(2022):
Update Breast Cancer 2022 Part 4-Advanced-Stage Breast Cancer.
In: Geburtshilfe und Frauenheilkunde, Bd. 82, Nr. 9: S. 922-931
Modi, Shanu; Jacot, William; Yamashita, Toshinari; Sohn, Joohyuk; Vidal, Maria; Tokunaga, Eriko; Tsurutani, Junji; Ueno, Naoto T.; Prat, Aleix; Chae, Yee Soo; Lee, Keun Seok; Niikura, Naoki; Park, Yeon Hee; Xu, Binghe; Wang, Xiaojia; Gil-Gil, Miguel; Li, Wei; Pierga, Jean-Yves; Im, Seock-Ah; Moore, Halle C. F.; Rugo, Hope S.; Yerushalmi, Rinat; Zagouri, Flora; Gombos, Andrea; Kim, Sung-Bae; Liu, Qiang; Luo, Ting; Saura, Cristina; Schmid, Peter; Sun, Tao; Gambhire, Dhiraj; Yung, Lotus; Wang, Yibin; Singh, Jasmeet; Vitazka, Patrik; Meinhardt, Gerold; Harbeck, Nadia und Cameron, David A.
(2022):
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.
In: New England Journal of Medicine, Bd. 387, Nr. 1: S. 9-20
Cortellini, Alessio; Gennari, Alessandra; Pommeret, Fanny; Patel, Grisma; Newsom-Davis, Thomas; Bertuzzi, Alexia; Viladot, Margarita; Aguilar-Company, Juan; Mirallas, Oriol; Felip, Eudald; Lee, Alvin J. X.; Dalla Pria, Alessia; Sharkey, Rachel; Brunet, Joan; Carmona-Garcia, Mcarmen; Chester, John; Mukherjee, Uma; Scotti, Lorenza; Dolly, Saoirse; Sita-Lumsden, Ailsa; Ferrante, Daniela; Hemelrijck, Mieke van; Moss, Charlotte; Russell, Beth; Segui, Elia; Biello, Federica; Krengli, Marco; Marco-Hernandez, Javier; Gaidano, Gianluca; Patriarca, Andrea; Bruna, Riccardo; Roldan, Elisa; Fox, Laura; Pous, Anna; Griscelli, Franck; Salazar, Ramon; Martinez-Vila, Clara; Sureda, Anna; Loizidou, Angela; Maluquer, Clara; Stoclin, Annabelle; Iglesias, Maria; Pedrazzoli, Paolo; Rizzo, Gianpiero; Santoro, Armando; Rimassa, Lorenza; Rossi, Sabrina; Harbeck, Nadia; de Torre, Ana Sanchez; Vincenzi, Bruno; Libertini, Michela; Provenzano, Salvatore; Generali, Daniele; Grisanti, Salvatore; Berardi, Rossana; Tucci, Marco; Mazzoni, Francesca; Lambertini, Matteo; Tagliamento, Marco; Parisi, Alessandro; Zoratto, Federica; Queirolo, Paola; Giusti, Raffaele; Guida, Annalisa; Zambelli, Alberto; Tondini, Carlo; Maconi, Antonio; Betti, Marta; Colomba, Emeline; Diamantis, Nikolaos; Sinclair, Alasdair; Bower, Mark; Ruiz-Camps, Isabel und Pinato, David J.
(2022):
COVID-19 Sequelae and the Host Proinflammatory Response: An Analysis From the OnCovid Registry.
In: Journal of the National Cancer Institute, Bd. 114, Nr. 7: S. 979-987
Arboleda, Bolivar; Bartsch, Rupert; de Azambuja, Evandro; Hamilton, Erika; Harbeck, Nadia; Klemp, Jennifer; Knauer, Michael; Kuemmel, Sherko; Mahtani, Reshma; Schwartzberg, Lee; Villarreal-Garza, Cynthia und Wolff, Antonio
(2022):
Ovarian Function Suppression: A Deeper Consideration of the Role in Early Breast Cancer and its Potential Impact on Patient Outcomes: A Consensus Statement from an International Expert Panel.
In: Oncologist, Bd. 27, Nr. 9: S. 722-731
Lu, Yen-Shen; Im, Seock-Ah; Colleoni, Marco; Franke, Fabio; Bardia, Aditya; Cardoso, Fatima; Harbeck, Nadia; Hurvitz, Sara; Chow, Louis; Sohn, Joohyuk; Lee, Keun Seok; Campos-Gomez, Saul; Vazquez, Rafael Villanueva; Jung, Kyung Hae; Babu, K. Govind; Wheatley-Price, Paul; De Laurentiis, Michelino; Im, Young-Hyuck; Kuemmel, Sherko; El-Saghir, Nagi; O'Regan, Ruth; Gasch, Claudia; Solovieff, Nadia; Wang, Craig; Wang, Yongyu; Chakravartty, Arunava; Ji, Yan und Tripathy, Debu
(2022):
Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2(-) Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical Trial.
In: Clinical Cancer Research, Bd. 28, Nr. 5: S. 851-859
Cristofanilli, Massimo; Rugo, Hope S.; Im, Seock-Ah; Slamon, Dennis J.; Harbeck, Nadia; Bondarenko, Igor; Masuda, Norikazu; Colleoni, Marco; DeMichele, Angela; Loi, Sherene; Iwata, Hiroji; O'Leary, Ben; Andre, Fabrice; Loibl, Sibylle; Bananis, Eustratios; Liu, Yuan; Huang, Xin; Kim, Sindy; Frean, Maria Jose Lechuga und Turner, Nicholas C.
(2022):
Overall Survival with Palbociclib and Fulvestrant in Women with HR+/HER2(- )ABC: Updated Exploratory Analyses of PALOMA-3, a Double-blind, Phase III Randomized Study.
In: Clinical Cancer Research, Bd. 28, Nr. 16: S. 3433-3442
Barrett, James E.; Herzog, Chiara; Kim, Yoo-Na; Bartlett, Thomas E.; Jones, Allison; Evans, Iona; Cibula, David; Zikan, Michal; Bjorge, Line; Harbeck, Nadia; Colombo, Nicoletta; Howell, Sacha J.; Radestad, Angelique Floter; Gemzell-Danielsson, Kristina und Widschwendter, Martin
(2022):
Susceptibility to hormone-mediated cancer is reflected by different tick rates of the epithelial and general epigenetic clock.
In: Genome Biology, Bd. 23, Nr. 1, 52
Erber, Ramona; Angeloni, Miriam; Stoehr, Robert; Lux, Michael P.; Ulbrich-Gebauer, Daniel; Pelz, Enrico; Bankfalvi, Agnes; Schmid, Kurt W.; Walter, Robert F. H.; Vetter, Martina; Thomssen, Christoph; Mayr, Doris; Klauschen, Frederick; Sinn, Peter; Sotlar, Karl; Stering, Katharina; Stenzinger, Albrecht; Wunderle, Marius; Fasching, Peter A.; Beckmann, Matthias W.; Hoffmann, Oliver; Kimmig, Rainer; Harbeck, Nadia; Wuerstlein, Rachel; Ferrazzi, Fulvia und Hartmann, Arndt
(2022):
Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist's Decision on Systemic Therapy in a Real-World Setting.
In: International Journal of Molecular Sciences, Bd. 23, Nr. 15, 8716
Trapp, Elisabeth K.; Fasching, Peter A.; Fehm, Tanja; Schneeweiss, Andreas; Mueller, Volkmar; Harbeck, Nadia; Lorenz, Ralf; Schumacher, Claudia; Heinrich, Georg; Schochter, Fabienne; de Gregorio, Amelie; Tzschaschel, Marie; Rack, Brigitte; Janni, Wolfgang und Friedl, Thomas W. P.
(2022):
Does the Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer Patients Predict the Site of First Metastasis-Results from the Adjuvant SUCCESS A Trial.
In: Cancers, Bd. 14, Nr. 16, 3949
Monti, Manuela; Degenhardt, Tom; Brain, Etienne; Würstlein, Rachel; Argusti, Alessandra; Puntoni, Matteo; Rollandi, Gian Andrea; Corradengo, Davide; Boni, Luca; Ilhan, Harun; Nanni, Oriana; Cortes, Javier; Piris-Gimenez, Alejandro; Piccardo, Arnoldo; Iacozzi, Massimiliano; Matteucci, Federica; Di Iorio, Valentina; Alberini, Jean Louis; Schroeder, Carolien; Harbeck, Nadia und Gennari, Alessandra
(2022):
ERANET JTC 2011: Submission and Activation of an International Academic Translational Project in Advanced Breast Cancer. Experience From the ET-FES Study.
In: Frontiers in Medicine, Bd. 8, 817678
Schildmann, Eva; Meesters, Sophie; Bausewein, Claudia; Gruene, Bettina; Licher, Ann Sophie; Bolzani, Anna; Remi, Constanze; Nuebling, Georg; Westphalen, C. Benedikt; Drey, Michael; Harbeck, Nadia und Hentrich, Marcus
(2022):
Sedatives and Sedation at the End of Life in the Hospital.
In: Deutsches Ärzteblatt International, Bd. 119, Nr. 21: S. 373-379
Hurvitz, Sara A.; Bachelot, Thomas; Bianchini, Giampaolo; Harbeck, Nadia; Loi, Sherene; Park, Yeon Hee; Prat, Aleix; Gilham, Leslie; Boulet, Thomas; Gochitashvili, Nino; Monturus, Estefania; Lambertini, Chiara; Nyawira, Beatrice; Knott, Adam; Restuccia, Eleonora und Schmid, Peter
(2022):
ASTEFANIA: adjuvant ado-trastuzumab emtansine and atezolizumab for high-risk, HER2-positive breast cancer.
In: Future Oncology, Bd. 18, Nr. 32: S. 3563-3572
Nitz, Ulrike A.; Gluz, Oleg; Kümmel, Sherko; Christgen, Matthias; Braun, Michael; Aktas, Bahriye; Lüdtke-Heckenkamp, Kerstin; Forstbauer, Helmut; Grischke, Eva-Maria; Schumacher, Claudia; Darsow, Maren; Krauss, Katja; Nuding, Benno; Thill, Marc; Potenberg, Jochem; Uleer, Christoph; Warm, Mathias; Fischer, Hans Holger; Malter, Wolfram; Hauptmann, Michael; Kates, Ronald E.; Gräser, Monika; Würstlein, Rachel; Shak, Steven; Baehner, Frederick; Kreipe, Hans H. und Harbeck, Nadia
(2022):
Endocrine Therapy Response and 21-Gene Expression Assay for Therapy Guidance in HR+/HP2-Early Breast Cancer.
In: Journal of Clinical Oncology, Bd. 40, Nr. 23: S. 2557-2567
Krop, Ian E.; Im, Seock-Ah; Barrios, Carlos; Bonnefoi, Herve; Gralow, Julie; Toi, Masakazu; Ellis, Paul A.; Gianni, Luca; Swain, Sandra M.; Im, Young-Hyuck; De Laurentiis, Michelino; Nowecki, Zbigniew; Huang, Chiun-Sheng; Fehrenbacher, Louis; Ito, Yoshinori; Shah, Jigna; Boulet, Thomas; Liu, Haiying; Macharia, Harrison; Trask, Peter; Song, Chunyan; Winer, Eric P. und Harbeck, Nadia
(2022):
Trastuzumab Emtansine Plus Pertuzumab Versus Taxane Plus Trastuzumab Plus Pertuzumab After Anthracycline for High-Risk Human Epidermal Growth Factor Receptor 2-Positive Early Breast Cancer: The Phase III KAITLIN Study.
In: Journal of Clinical Oncology, Bd. 40, Nr. 5: S. 438-448
Gluz, Oleg; Nitz, Ulrike; Kolberg-Liedtke, Cornelia; Prat, Aleix; Christgen, Matthias; Kuemmel, Sherko; Mohammadian, Mohammad Parsa; Gebauer, Daniel; Kates, Ronald; Pare, Laia; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Wuerstlein, Rachel; Graeser, Monika; Pelz, Enrico; Jozwiak, Katarzyna; Zu Eulenburg, Christine; Kreipe, Hans Heinrich und Harbeck, Nadia
(2022):
De-escalated Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer (TNBC): Impact of Molecular Markers and Final Survival Analysis of the WSG-ADAPT-TN Trial.
In: Clinical Cancer Research, Bd. 28, Nr. 22: S. 4995-5003
Kolberg-Liedtke, Cornelia; Feuerhake, Friedrich; Garke, Madlen; Christgen, Matthias; Kates, Ronald; Grischke, Eva Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Kuemmel, Sherko; Wuerstlein, Rachel; Graeser, Monika; Nitz, Ulrike; Kreipe, Hans; Gluz, Oleg und Harbeck, Nadia
(2022):
Impact of stromal tumor-infiltrating lymphocytes (sTILs) on response to neoadjuvant chemotherapy in triple-negative early breast cancer in the WSG-ADAPT TN trial.
In: Breast Cancer Research, Bd. 24, Nr. 1, 58
Kreipe, Hans; Harbeck, Nadia und Christgen, Matthias
(2022):
Clinical validity and clinical utility of Ki67 in early breast cancer.
In: Therapeutic Advances in Medical Oncology, Bd. 14
Ditsch, Nina; Woecke, Achim; Untch, Michael; Jackisch, Christian; Albert, Ute-Susann; Banys-Paluchowski, Maggie; Bauerfeind, Ingo; Blohmer, Jens-Uwe; Budach, Wilfried; Dall, Peter; Fallenberg, Eva Maria; Fasching, Peter A.; Fehm, Tanja N.; Friedrich, Michael; Gerber, Bernd; Gluz, Oleg; Harbeck, Nadia; Heil, Jörg; Huober, Jens; Kreipe, Hans H.; Krug, David; Kuehn, Thorsten; Kuemmel, Sherko; Kolberg-Liedtke, Cornelia; Loibl, Sibylle; Lueftner, Diana; Lux, Michael Patrick; Maass, Nicolai; Mundhenke, Christoph; Nitz, Ulrike; Park-Simon, Tjoung-Won; Reimer, Toralf; Rhiem, Kerstin; Rody, Achim; Schmidt, Marcus; Schneeweiss, Andreas; Schuetz, Florian; Sinn, Hans-Peter; Solbach, Christine; Solomayer, Erich-Franz; Stickeler, Elmar; Thomssen, Christoph; Witzel, Isabell; Mueller, Volkmar; Janni, Wolfgang und Thill, Marc
(2022):
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2022.
In: Breast Care, Bd. 17, Nr. 4: S. 403-420
Thill, Marc; Lueftner, Diana; Kolberg-Liedtke, Cornelia; Albert, Ute-Susann; Banys-Paluchowski, Maggie; Bauerfeind, Ingo; Blohmer, Jens-Uwe; Budach, Wilfried; Dall, Peter; Fallenberg, Eva Maria; Fasching, Peter A.; Fehm, Tanja; Friedrich, Michael; Gerber, Bernd; Gluz, Oleg; Harbeck, Nadia; Heil, Joerg; Huober, Jens; Jackisch, Christian; Kreipe, Hans-Heinrich; Krug, David; Kuehn, Thorsten; Kuemmel, Sherko; Loibl, Sibylle; Lux, Michael; Maass, Nicolai; Mundhenke, Christoph; Nitz, Ulrike; Park-Simon, Tjoung-Won; Reimer, Toralf; Rhiem, Kerstin; Rody, Achim; Schmidt, Marcus; Schneeweiss, Andreas; Schuetz, Florian; Sinn, Hans-Peter; Solbach, Christine; Solomayer, Erich-Franz; Stickeler, Elmar; Thomssen, Christoph; Untch, Michael; Witzel, Isabell; Woeckel, Achim; Mueller, Volkmar; Janni, Wolfgang und Ditsch, Nina
(2022):
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2022.
In: Breast Care, Bd. 17, Nr. 4: S. 421-429
Dimpfl, Moritz; Mayr, Doris; Schmoeckel, Elisa; Degenhardt, Tom; Eggersmann, Tanja K.; Harbeck, Nadia und Wuerstlein, Rachel
(2022):
Hormone Receptor and HER2 Status Switch in Non-pCR Breast Cancer Specimens after Neoadjuvant Therapy.
In: Breast Care, Bd. 17, Nr. 5: S. 501-507
Lüftner, Diana; Fasching, Peter A.; Haidinger, Renate; Harbeck, Nadia; Jackisch, Christian; Müller, Volkmar; Schumacher-Wulf, Eva; Thomssen, Christoph; Untch, Michael und Würstlein, Rachel
(2022):
ABC6 Consensus: Assessment by a Group of German Experts.
In: Breast Care, Bd. 17, Nr. 1: S. 90-100
Kolberg-Liedtke, Cornelia; Lüftner, Diana; Brucker, Sara Y.; Budach, Wilfried; Denkert, Carsten; Fasching, Peter A.; Haidinger, Renate; Harbeck, Nadia; Huober, Jens; Jackisch, Christian; Janni, Wolfgang; Krug, David; Kühn, Thorsten; Loibl, Sibylle; Müller, Volkmar; Schneeweiss, Andreas; Thomssen, Christoph; Untch, Michael und Thill, Marc
(2022):
Practice-Changing Perspectives regarding Systemic Therapy in Early Breast Cancer: Opinions of German Experts regarding the 17th St. Gallen International Consensus Conference.
In: Breast Care, Bd. 17, Nr. 3: S. 336-345
Shao, Wanting; Kuhn, Christina; Mayr, Doris; Ditsch, Nina; Kailuwait, Magdalena; Wolf, Verena; Harbeck, Nadia; Mahner, Sven; Jeschke, Udo; Cavaillès, Vincent und Sixou, Sophie
(2021):
Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer.
In: Journal of cancer research and clinical oncology, Bd. 147, Nr. 9: S. 2535-2544
[PDF, 1MB]
Karsten, Nora; Kolben, Thomas; Mahner, Sven; Beyer, Susanne; Meister, Sarah; Kuhn, Christina; Schmoeckel, Elisa; Wuerstlein, Rachel; Harbeck, Nadia; Ditsch, Nina; Jeschke, Udo; Friese, Klaus und Kolben, Theresa Maria
(2021):
The role of E-Cadherin expression in primary site of breast cancer.
In: Archives of gynecology and obstetrics
[PDF, 796kB]
Kaltofen, Till; Hagemann, Friederike; Harbeck, Nadia ORCID: https://orcid.org/0000-0002-9744-7372; Wuerstlein, Rachel; Kost, Bernd Peter; Burges, Alexander; Mahner, Sven und Trillsch, Fabian
(2021):
Changes in gynecologic and breast cancer diagnoses during the first wave of the COVID-19 pandemic: analysis from a tertiary academic gyneco-oncological center in Germany.
In: Archives of gynecology and obstetrics
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-9744-7372; Wuerstlein, Rachel; Kost, Bernd Peter; Burges, Alexander; Mahner, Sven und Trillsch, Fabian
(2021):
Changes in gynecologic and breast cancer diagnoses during the first wave of the COVID-19 pandemic: analysis from a tertiary academic gyneco-oncological center in Germany.
In: Archives of gynecology and obstetrics
[PDF, 1MB]
Aftimos, Philippe; Oliveira, Mafalda; Irrthum, Alexandre; Fumagalli, Debora; Sotiriou, Christos; Gal-Yam, Einav Nili; Robson, Mark E.; Ndozeng, Justin; Di Leo, Angelo; Ciruelos, Eva M.; de Azambuja, Evandro; Viale, Giuseppe; Scheepers, Elsemieke D.; Curigliano, Giuseppe; Bliss, Judith M.; Reis-Filho, Jorge S.; Colleoni, Marco; Balic, Marija; Cardoso, Fatima; Albanell, Joan; Duhem, Caroline; Marreaud, Sandrine; Romagnoli, Dario; Rojas, Beatriz; Gombos, Andrea; Wildiers, Hans; Guerrero-Zotano, Angel; Hall, Peter; Bonetti, Andrea; Larsson, Karolina Fs; Degiorgis, Martina; Khodaverdi, Silvia; Greil, Richard; Sverrisdottir, Asgerdur; Paoli, Marta; Seyll, Ethel; Loibl, Sibylle; Linderholm, Barbro; Zoppoli, Gabriele; Davidson, Nancy E.; Johannsson, Oskar Th; Bedard, Philippe L.; Loi, Sherene; Knox, Susan; Cameron, David A.; Harbeck, Nadia; Montoya, Maite Lasa; Brandao, Mariana; Vingiani, Andrea; Caballero, Carmela; Hilbers, Florentine S.; Yates, Lucy R.; Benelli, Matteo; Venet, David und Piccart, Martine J.
(2021):
Genomic and Transcriptomic Analyses of Breast Cancer Primaries and Matched Metastases in AURORA, the Breast International Group (BIG) Molecular Screening Initiative.
In: Cancer Discovery, Bd. 11, Nr. 11: S. 2796-2811
Bardia, Aditya; Su, Fei; Solovieff, Nadia; Im, Seock-Ah; Sohn, Joohyuk; Lee, Keun Seok; Campos-Gomez, Saul; Jung, Kyung Hae; Colleoni, Marco; Villanueva Vazquez, Rafael; Franke, Fabio; Hurvitz, Sara; Harbeck, Nadia; Chow, Louis; Taran, Tetiana; Lorenc, Karen Rodriguez; Babbar, Naveen; Tripathy, Debu und Lu, Yen-Shen
(2021):
Genomic Profiling of Premenopausal HR+ and HER2-Metastatic Breast Cancer by Circulating Tumor DNA and Association of Genetic Alterations With Therapeutic Response to Endocrine Therapy and Ribociclib.
In: Jco Precision Oncology, Bd. 5: S. 1408-1420
Bottoni, Gianluca; Piccardo, Arnoldo; Fiz, Francesco; Siri, Giacomo; Matteucci, Federica; Rocca, Andrea; Nanni, Oriana; Monti, Manuela; Brain, Etienne; Alberini, Jean Louis; Dib, Bassam; Sacchetti, Gian Mauro; Saggia, Chiara; Rossi, Valentina; Harbeck, Nadia; Wuerstlein, Rachel; Degenhardt, Tom; DeCensi, Andrea; Rollandi, Gian Andrea und Gennari, Alessandra
(2021):
Heterogeneity of bone metastases as an important prognostic factor in patients affected by oestrogen receptor-positive breast cancer. The role of combined [18F]Fluoroestradiol PET/CT and [18F] Fluorodeoxyglucose PET/CT.
In: European Journal of Radiology, Bd. 141, 109821
Cardoso, Fatima; Cella, David; Velikova, Galina; Harmer, Victoria; Schumacher-Wulf, Eva; Rihani, Julie; Casas, Ana und Harbeck, Nadia
(2021):
Quality-of-life methodology in hormone receptor-positive advanced breast cancer: Current tools and perspectives for the future.
In: Cancer Treatment Reviews, Bd. 102, 102321
Chelariu-Raicu, Anca und Harbeck, Nadia
(2021):
Treatment Landscape of Ductal Carcinoma In Situ.
In: Chirurgia, Bd. 116, Nr. 5:
S76-S82
Christgen, Matthias; Kandt, Leonie Donata; Antonopoulos, Wiebke; Bartels, Stephan; Bockstal, Mieke R. van; Bredt, Martin; Brito, Maria Jose; Christgen, Henriette; Colpaert, Cecile; Cserni, Balint; Cserni, Gabor; Daemmrich, Maximilian E.; Danebrock, Raihanatou; Dedeurwaerdere, Franceska; Deurzen, Carolien H. M. van; Erber, Ramona; Fathke, Christine; Feist, Henning; Fiche, Maryse; Gonzalez, Claudia Aura; Hoeve, Natalie D. ter; Kooreman, Loes; Krech, Till; Kristiansen, Glen; Kulka, Janina; Laenger, Florian; Lafos, Marcel; Lehmann, Ulrich; Martin-Martinez, Maria Dolores; Mueller, Sophie; Pelz, Enrico; Raap, Mieke; Ravarino, Alberto; Reineke-Plaass, Tanja; Schaumann, Nora; Schelfhout, Anne-Marie; Schepper, Maxim de; Schlue, Jerome; Vijver, Koen van de; Waelput, Wim; Wellmann, Axel; Graeser, Monika; Gluz, Oleg; Kuemmel, Sherko; Nitz, Ulrike; Harbeck, Nadia; Desmedt, Christine; Floris, Giuseppe; Derksen, Patrick W. B.; Diest, Paul J. van; Vincent-Salomon, Anne und Kreipe, Hans
(2021):
Inter-observer agreement for the histological diagnosis of invasive lobular breast carcinoma.
In: Journal of Pathology Clinical Research, Bd. 8, Nr. 2: S. 191-205
Dettorre, Gino M.; Dolly, Saoirse; Loizidou, Angela; Chester, John; Jackson, Amanda; Mukherjee, Uma; Zambelli, Alberto; Aguilar-Company, Juan; Bower, Mark; Sng, Christopher C. T.; Salazar, Ramon; Bertuzzi, Alexia; Brunet, Joan; Mesia, Ricard; Sita-Lumsden, Ailsa; Segui, Elia; Biello, Federica; Generali, Daniele; Grisanti, Salvatore; Seeva, Pavetha; Rizzo, Gianpiero; Libertini, Michela; Maconi, Antonio; Moss, Charlotte; Russell, Beth; Harbeck, Nadia; Vincenzi, Bruno; Bertulli, Rossella; Ottaviani, Diego; Linan, Raquel; Marrari, Andrea; Carmona-Garcia, M. Carmen; Chopra, Neha; Tondini, Carlo Alberto; Mirallas, Oriol; Tovazzi, Valeria; Fotia, Vittoria; Cruz, Claudia Andrea; Saoudi-Gonzalez, Nadia; Felip, Eudald; Roque, Ariadna; Lee, Alvin J. X.; Newsom-Davis, Tom; Garcia-Illescas, David; Reyes, Roxana; Wong, Yien Ning Sophia; Ferrante, Daniela; Scotti, Lorenza; Marco-Hernandez, Javier; Ruiz-Camps, Isabel; Patriarca, Andrea; Rimassa, Lorenza; Chiudinelli, Lorenzo; Franchi, Michela; Santoro, Armando; Prat, Aleix; Gennari, Alessandra; Hemelrijck, Mieke van; Tabernero, Josep; Diamantis, Nikolaos und Pinato, David J.
(2021):
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score.
In: Journal for Immunotherapy of Cancer, Bd. 9, Nr. 3, e002277
Forster, Marie; Würstlein, Rachel; Koenig, Alexander; Amann, Niklas; Beyer, Susanne; Kaltofen, Till; Degenhardt, Tom; Burges, Alexander; Trillsch, Fabian; Mahner, Sven; Harbeck, Nadia und Chelariu-Raicu, Anca
(2021):
COVID-19 vaccination in patients with breast cancer and gynecological malignancies: A German perspective.
In: Breast, Bd. 60: S. 214-222
Garrigos, Laia; Saura, Cristina; Martinez-Vila, Clara; Zambelli, Alberto; Bower, Mark; Pistilli, Barbara; Lambertini, Matteo; Ottaviani, Diego; Diamantis, Nikolaos; Lumsden, Ailsa; Pernas, Sonia; Generali, Daniele; Segui, Elia; Vinas, Gemma; Felip, Eudald; Sanchez, Ana; Rizzo, Gianpiero; Santoro, Armando; Cortellini, Alessio; Perone, Ylenia; Chester, John; Iglesias, Maria; Betti, Marta; Vincenzi, Bruno; Libertini, Michela; Mazzoni, Francesca; Zoratto, Federica; Berardi, Rossana; Guida, Annalisa; Wuerstlein, Rachel; Loizidou, Angela; Sharkey, Rachel; Aguilar Company, Juan; Matas, Marta; Saggia, Chiara; Chiudinelli, Lorenzo; Colomba-Blameble, Emeline; Galazi, Myria; Mukherjee, Uma; Hemelrijck, Mieke van; Marin, Mar; Strina, Carla; Prat, Aleix; Pla, Helena; Ciruelos, Eva Maria; Bertuzzi, Alexia; del Mastro, Lucia; Porzio, Giampiero; Newsom-Davis, Thomas; Ruiz, Isabel; Delany, Maria Belen; Krengli, Marco; Fotia, Vittoria; Viansone, Alessandro; Chopra, Neha; Romeo, Margarita; Salazar, Ramon; Perez, Ignacio; d'Avanzo, Francesca; Franchi, Michela; Milani, Manuela; Pommeret, Fanny; Tucci, Marco; Pedrazzoli, Paolo; Harbeck, Nadia; Ferrante, Daniela; Pinato, David J. und Gennari, Alessandra
(2021):
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry.
In: Therapeutic Advances in Medical Oncology, Bd. 13, 17588359211053416
Graeser, Monika; Feuerhake, Friedrich; Gluz, Oleg; Volk, Valery; Hauptmann, Michael; Jozwiak, Katarzyna; Christgen, Matthias; Kuemmel, Sherko; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Kolberg-Liedtke, Cornelia; Kates, Ronald; Wuerstlein, Rachel; Nitz, Ulrike; Kreipe, Hans Heinrich und Harbeck, Nadia
(2021):
Immune cell composition and functional marker dynamics from multiplexed immunohistochemistry to predict response to neoadjuvant chemotherapy in the WSG-ADAPT-TN trial.
In: Journal for Immunotherapy of Cancer, Bd. 9, Nr. 5, e002198
Graeser, Monika; Harbeck, Nadia; Gluz, Oleg; Wuerstlein, Rachel; Eulenburg, Christine zu; Schumacher, Claudia; Grischke, Eva -Maria; Forstbauer, Helmut; Dimpfl, Moritz; Braun, Michael; Christgen, Matthias; Kreipe, Hans Heinrich; Potenberg, Jochem; Schumann, Raquel von; Aktas, Bahriye; Kolberg-Liedtke, Cornelia; Kuemmel, Sherko und Nitz, Ulrike
(2021):
The use of breast ultrasound for prediction of pathologic complete response in different subtypes of early breast cancer within the WSG-ADAPT subtrials.
In: Breast, Bd. 59: S. 58-66
Graeser, Monika; Schrading, Simone; Gluz, Oleg; Strobel, Kevin; Herzog, Christopher; Umutlu, Lale; Frydrychowicz, Alex; Rjosk-Dendorfer, Dorothea; Wuerstlein, Rachel; Culemann, Ralph; Eulenburg, Christine; Adams, Jascha; Nitzsche, Henrik; Prange, Anna; Kuemmel, Sherko; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Potenberg, Jochem; Schumann, Raquel von; Aktas, Bahriye; Kolberg-Liedtke, Cornelia; Harbeck, Nadia; Kuhl, Christiane K. und Nitz, Ulrike
(2021):
Magnetic resonance imaging and ultrasound for prediction of residual tumor size in early breast cancer within the ADAPT subtrials.
In: Breast Cancer Research, Bd. 23, Nr. 1, 36
Graeser, Monika; Schrading, Simone; Gluz, Oleg; Strobel, Kevin; Wuerstlein, Rachel; Kuemmel, Sherko; Schumacher, Claudia; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Christgen, Matthias; Adams, Jascha; Nitzsche, Henrik; Just, Marianne; Fischer, Hans Holger; Aktas, Bahriye; Potenberg, Jochem; Schumann, Raquel von; Kolberg-Liedtke, Cornelia; Harbeck, Nadia; Kuhl, Christiane K. und Nitz, Ulrike
(2021):
Early response by MR imaging and ultrasound as predictor of pathologic complete response to 12-week neoadjuvant therapy for different early breast cancer subtypes: Combined analysis from the WSG ADAPT subtrials.
In: International Journal of Cancer, Bd. 148, Nr. 10: S. 2614-2627
Grote, Isabel; Bartels, Stephan; Kandt, Leonie; Bollmann, Laura; Christgen, Henriette; Gronewold, Malte; Raap, Mieke; Lehmann, Ulrich; Gluz, Oleg; Nitz, Ulrike; Kuemmel, Sherko; Zu Eulenburg, Christine; Braun, Michael; Aktas, Bahriye; Grischke, Eva-Maria; Schumacher, Claudia; Luedtke-Heckenkamp, Kerstin; Kates, Ronald; Wuerstlein, Rachel; Graeser, Monika; Harbeck, Nadia; Christgen, Matthias und Kreipe, Hans
(2021):
TP53 mutations are associated with primary endocrine resistance in luminal early breast cancer.
In: Cancer Medicine, Bd. 10, Nr. 23: S. 8581-8594
Harbeck, Nadia
(2021):
Risk-adapted adjuvant therapy of luminal early breast cancer in 2020.
In: Current Opinion in Obstetrics & Gynecology, Bd. 33, Nr. 1: S. 53-58
Harbeck, Nadia; Bartlett, Meaghan; Spurden, Dean; Hooper, Becky; Zhan, Lin; Rosta, Emily; Cameron, Chris; Mitra, Debanjali und Zhou, Anna
(2021):
CDK4/6 inhibitors in HR+/HER2-advanced/metastatic breast cancer: a systematic literature review of real-world evidence studies.
In: Future Oncology, Bd. 17, Nr. 16: S. 2107-2122
Harbeck, Nadia; Schneeweiss, Andreas; Thuss-Patience, Peter; Miller, Kurt; Garbe, Claus; Griesinger, Frank; Eberhardt, Wilfried E. E.; Klussmann, Jens P.; Wollenberg, Barbara; Grimm, Marc-Oliver; Zander, Thomas und Lueftner, Diana
(2021):
Neoadjuvant and adjuvant end-points in health technology assessment in oncology.
In: European Journal of Cancer, Bd. 147: S. 40-50
Harbeck, Nadia; Schumann, Raquel von; Kates, Ronald Ernest; Braun, Michael; Kuemmel, Sherko; Schumacher, Claudia; Potenberg, Jochem; Malter, Wolfram; Augustin, Doris; Aktas, Bahriye; Forstbauer, Helmut; Tio, Joke; Grischke, Eva-Maria; Biehl, Claudia; Liedtke, Cornelia; Haas, Sanne Lysbet de; Deurloo, Regula; Wuerstlein, Rachel; Kreipe, Hans Heinrich und Gluz, Oleg
(2021):
Immune Markers and Tumor-Related Processes Predict Neoadjuvant Therapy Response in the WSG-ADAPT HER2-Positive/Hormone Receptor-Positive Trial in Early Breast Cancer.
In: Cancers, Bd. 13, Nr. 19, 4884
Hartkopf, Andreas D.; Brucker, Sara Y.; Taran, Florin-Andrei; Harbeck, Nadia; Au, Alexandra von; Naume, Bjorn; Pierga, Jean-Yves; Hoffmann, Oliver; Beckmann, Matthias W.; Ryden, Lisa; Fehm, Tanja; Aft, Rebecca; Sola, Montserrat; Walter, Vincent; Rack, Brigitte; Schuetz, Florian; Borgen, Elin; Ta, Minh-Hanh; Bittner, Ann-Kathrin; Fasching, Peter A.; Ferno, Marten; Krawczyk, Natalia; Weilbaecher, Katherine; Margeli, Mireia; Hahn, Markus; Jueckstock, Julia; Domschke, Christoph; Bidard, Francois-Clement; Kasimir-Bauer, Sabine; Schoenfisch, Birgitt; Kurt, Ayse G.; Wallwiener, Markus; Gebauer, Gerhard; Klein, Christoph A.; Wallwiener, Diethelm; Janni, Wolfgang und Pantel, Klaus
(2021):
Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysis.
In: European Journal of Cancer, Bd. 154: S. 128-137
Hester, Anna; Henze, Franziska; Travi, Christiane; Harbeck, Nadia und Würstlein, Rachel
(2021):
First Experiences with Alpelisib in Clinical Routine: Case Reports from a German Breast Center.
In: Breast Care, Bd. 16, Nr. 2: S. 129-134
Huber, Marinus; Kepesidis, Kosmas; Voronina, Liudmila; Bozic, Masa; Trubetskov, Michael; Harbeck, Nadia; Krausz, Ferenc ORCID: https://orcid.org/0000-0002-6525-9449 und Zigman, Mihaela
(2021):
Stability of person-specific blood-based infrared molecular fingerprints opens up prospects for health monitoring.
In: Nature Communications, Bd. 12, Nr. 1, 1511
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-6525-9449 und Zigman, Mihaela
(2021):
Stability of person-specific blood-based infrared molecular fingerprints opens up prospects for health monitoring.
In: Nature Communications, Bd. 12, Nr. 1, 1511
[PDF, 1MB]
Huber, Marinus; Kepesidis, Kosmas; Voronina, Liudmila; Fleischmann, Frank; Fill, Ernst; Hermann, Jacqueline; Koch, Ina; Milger-Kneidinger, Katrin; Kolben, Thomas; Schulz, Gerald B.; Jokisch, Friedrich; Behr, Jürgen; Harbeck, Nadia; Reiser, Maximilian; Stief, Christian; Krausz, Ferenc ORCID: https://orcid.org/0000-0002-6525-9449 und Zigman, Mihaela
(2021):
Infrared molecular fingerprinting of blood-based liquid biopsies for the detection of cancer.
In: eLife, Bd. 10, e68758
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-6525-9449 und Zigman, Mihaela
(2021):
Infrared molecular fingerprinting of blood-based liquid biopsies for the detection of cancer.
In: eLife, Bd. 10, e68758
[PDF, 1MB]
Jackisch, Christian; Barcenas, Carlos H.; Bartsch, Rupert; Di Palma, Jack; Glueck, Stefan; Harbeck, Nadia; Macedo, Guilherme; O'Shaughnessy, Joyce; Pistilli, Barbara; Ruiz-Borrego, Manuel und Rugo, Hope S.
(2021):
Optimal Strategies for Successful Initiation of Neratinib in Patients with HER2-Positive Breast Cancer.
In: Clinical Breast Cancer, Bd. 21, Nr. 5, E575-E583
Kaltofen, Till; Hagemann, Friederike; Harbeck, Nadia; Würstlein, Rachel; Kost, Bernd Peter; Burges, Alexander; Mahner, Sven und Trillsch, Fabian
(2021):
Changes in gynecologic and breast cancer diagnoses during the first wave of the COVID-19 pandemic: analysis from a tertiary academic gyneco-oncological center in Germany.
In: Archives of Gynecology and Obstetrics, Bd. 305, Nr. 3: S. 713-718
Karsten, Nora; Kolben, Thomas; Mahner, Sven; Beyer, Susanne; Meister, Sarah; Kuhn, Christina; Schmoeckel, Elisa; Würstlein, Rachel; Harbeck, Nadia; Ditsch, Nina; Jeschke, Udo; Friese, Klaus und Kolben, Theresa Maria
(2021):
The role of E-Cadherin expression in primary site of breast cancer.
In: Archives of Gynecology and Obstetrics, Bd. 305, Nr. 4: S. 913-920
Kolben, Thomas; Beyer, Susanne; Ghasemi, Sanaz; Hermelink, Kerstin; Meister, Sarah; Degenhardt, Tom; Himsl, Isabelle; Edler von Koch, Franz; Kolben, Theresa M.; Würstlein, Rachel; Mahner, Sven; Harbeck, Nadia und Hester, Anna
(2021):
Late Presentation at Primary Diagnosis of Breast Cancer: Patients' Personality Characteristics and Attitudes.
In: Breast Care, Bd. 16, Nr. 4: S. 343-349
Krajnak, Slavomir; Decker, Thomas; Schollenberger, Lukas; Rose, Christian; Ruckes, Christian; Fehm, Tanja; Thomssen, Christoph; Harbeck, Nadia und Schmidt, Marcus
(2021):
Phase II study of metronomic treatment with daily oral vinorelbine as first-line chemotherapy in patients with advanced/metastatic HR+/HER2-breast cancer resistant to endocrine therapy: VinoMetro-AGO-B-046.
In: Journal of Cancer Research and Clinical Oncology, Bd. 147, Nr. 11: S. 3391-3400
Lueftner, Diana; Tesch, Hans; Schmidt, Marcus; Hartkopf, Andreas D.; Streicher, Sarah; Resch, Anna; Genovese, Luca; Rose, Christian; Valenti, Roberta und Harbeck, Nadia
(2021):
Neratinib as extended adjuvant therapy in patients with copositive early breast cancer: German health technology assessment-driven analyses from the ExteNET study.
In: European Journal of Cancer, Bd. 150: S. 268-277
Lux, Michael P.; Decker, Thomas; Runkel, Eva Diana; Niyazov, Alexander; Quek, Ruben G. W.; Marschner, Norbert und Harbeck, Nadia
(2021):
Awareness and Availability of Routine Germline BRCA1/2 Mutation Testing in Patients with Advanced Breast Cancer in Germany.
In: Breast Care, Bd. 17, Nr. 1: S. 40-46
Lux, Michael P.; Schneeweiss, Andreas; Hartkopf, Andreas D.; Mueller, Volkmar; Janni, Wolfgang; Belleville, Erik; Stickeler, Elmar; Thill, Marc; Fasching, Peter A.; Kolberg, Hans-Christian; Untch, Michael; Harbeck, Nadia; Woeckel, Achim; Thomssen, Christoph; Schulmeyer, Carla E.; Welslau, Manfred; Overkamp, Friedrich; Schuetz, Florian; Lueftner, Diana und Ditsch, Nina
(2021):
Update Breast Cancer 2020 Part 5-Moving Therapies From Advanced to Early Breast Cancer Patients.
In: Geburtshilfe und Frauenheilkunde, Bd. 81, Nr. 4: S. 469-480
Ni, Hua; Kumbrink, Jörg; Mayr, Doris; Seiler, Alina; Hagemann, Friederike; Degenhardt, Tom; Sagebiel, Sabine; Würstlein, Rachel; Kates, Ronald; Harbeck, Nadia und Eggersmann, Tanja K.
(2021):
Molecular Prognostic Factors for Distant Metastases in Premenopausal Patients with HR+/HER2- Early Breast Cancer.
In: Journal of Personalized Medicine, Bd. 11, Nr. 9, 835
Onesti, Concetta Elisa; Tagliamento, Marco; Curigliano, Giuseppe; Harbeck, Nadia; Bartsch, Rupert; Wildiers, Hans; Tjan-Heijnen, Vivianne; Martin, Miguel; Rottey, Sylvie; Generali, Daniele; Campone, Mario; Cristofanilli, Massimo; Pusztai, Lajos; Peeters, Marc; Berchem, Guy; Cortes, Javier; Ruhstaller, Thomas; Ciruelos, Eva; Rugo, Hope S. und Jerusalem, Guy
(2021):
Expected Medium- and Long-Term Impact of the COVID-19 Outbreak in Oncology.
In: Jco Global Oncology, Bd. 7: S. 162-172
O'Shaughnessy, Joyce A.; Johnston, Stephen; Harbeck, Nadia; Toi, Masakazu; Im, Young-Hyuck; Reinisch, Mattea; Shao, Zhimin; Lehtinen, Pirkko Liisa Kellokumpu; Huang, Chiun-Sheng; Tryakin, Alexey; Goetz, Matthew; Rugo, Hope S.; Senkus, Elzbieta; Testa, Laura; Andersson, Michael; Tamura, Kenji; Steger, Guenther G.; Del Mastro, Lucia; Cox, Joanne; Forrester, Tammy; Sherwood, Sarah; Li, Xuelin; Wei, Ran; Martin, Miguel und Rastogi, Priya
(2021):
Primary Outcome Analysis of Invasive Disease-Free Survival for MonarchE: Abemaciclib Combined With Adjuvant Endocrine Therapy for High-Risk Early Breast Cancer.
In: Clinical Advances in Hematology & Oncology, Bd. 19, Nr. 2: S. 15-16
O'Shaughnessy, Joyce; Schwartzberg, Lee; Piccart, Martine; Rugo, Hope S.; Yardley, Denise A.; Cortes, Javier; Untch, Michael; Harbeck, Nadia; Wright, Gail S.; Bondarenko, Igor; Glaspy, John; Nowecki, Zbigniew; Kayali, Fadi; Chan, Arlene; Levy, Christelle; Liu, Mei-Ching; Kim, Sung-Bae; Lemieux, Julie; Manikhas, Alexey; Tolaney, Sara; Lim, Elaine; Gombos, Andrea; Stradella, Agostina; Pegram, Mark; Fasching, Peter; Mangel, Laszlo; Semiglazov, Vladimir; Dieras, Veronique; Gianni, Luca; Danso, Michael A.; Vacirca, Jeff; Kroll, Stew; O'Connell, Joseph; Tang, Kevin; Wei, Thomas und Seidman, Andrew
(2021):
Results From CONTESSA: A Phase 3 Study of Tesetaxel Plus a Reduced Dose of Capecitabine Versus Capecitabine Alone in Patients With HER2-, Hormone Receptor+ Metastatic Breast Cancer Who Have Previously Received a Taxane.
In: Clinical Advances in Hematology & Oncology, Bd. 19, Nr. 2: S. 12-13
Pascual, Tomas; Oliveira, Mafalda; Villagrasa, Patricia; Ortega, Vanesa; Pare, Laia; Bermejo, Begona; Morales, Serafin; Amillano, Kepa; Lopez, Rafael; Galvan, Patricia; Canes, Jordi; Salvador, Fernando; Nuciforo, Paolo; Rubio, Isabel T.; Llombart-Cussac, Antonio; Di Cosimo, Serena; Baselga, Jose; Harbeck, Nadia; Prat, Aleix und Cortes, Javier
(2021):
Neoadjuvant eribulin in HER2-negative early-stage breast cancer (SOLTI-1007-NeoEribulin): a multicenter, two-cohort, non-randomized phase II trial.
In: Npj Breast Cancer, Bd. 7, Nr. 1, 145
Pichler, Theresia; Marten-Mittag, Birgitt; Hermelink, Kerstin; Telzerow, Eva; Frank, Tamara; Ackermann, Ulrike; Belka, Claus; Combs, Stephanie E.; Gratzke, Christian; Gschwend, Jürgen; Harbeck, Nadia; Heinemann, Volker; Herkommer, Kathleen; Kiechle, Marion; Mahner, Sven; Pigorsch, Steffi; Rauch, Josefine; Stief, Christian; Mumm, Friederike; Heussner, Pia; Herschbach, Peter und Dinkel, Andreas
(2021):
Distress in hospitalized cancer patients: Associations with personality traits, clinical and psychosocial characteristics.
In: Psycho-Oncology, Bd. 31, Nr. 5: S. 770-778
Pinato, David J.; Patel, Meera; Scotti, Lorenza; Colomba, Emeline; Dolly, Saoirse; Loizidou, Angela; Chester, John; Mukherjee, Uma; Zambelli, Alberto; Dalla Pria, Alessia; Aguilar-Company, Juan; Bower, Mark; Salazar, Ramon; Bertuzzi, Alexia; Brunet, Joan; Lambertini, Matteo; Tagliamento, Marco; Pous, Anna; Sita-Lumsden, Ailsa; Srikandarajah, Krishnie; Colomba, Johann; Pommeret, Fanny; Segui, Elia; Generali, Daniele; Grisanti, Salvatore; Pedrazzoli, Paolo; Rizzo, Gianpiero; Libertini, Michela; Moss, Charlotte; Evans, Joanne S.; Russell, Beth; Harbeck, Nadia; Vincenzi, Bruno; Biello, Federica; Bertulli, Rossella; Ottaviani, Diego; Linan, Raquel; Rossi, Sabrina; Carmona-Garcia, M. Carmen; Tondini, Carlo; Fox, Laura; Baggi, Alice; Fotia, Vittoria; Parisi, Alessandro; Porzio, Giampero; Queirolo, Paola; Cruz, Claudia Andrea; Saoudi-Gonzalez, Nadia; Felip, Eudald; Roque Lloveras, Ariadna; Newsom-Davis, Thomas; Sharkey, Rachel; Roldan, Elisa; Reyes, Roxana; Zoratto, Federica; Earnshaw, Irina; Ferrante, Daniela; Marco-Hernandez, Javier; Ruiz-Camps, Isabel; Gaidano, Gianluca; Patriarca, Andrea; Bruna, Riccardo; Sureda, Anna; Martinez-Vila, Clara; Sanchez de Torre, Ana; Berardi, Rossana; Giusti, Raffaele; Mazzoni, Francesca; Guida, Annalisa; Rimassa, Lorenza; Chiudinelli, Lorenzo; Franchi, Michela; Krengli, Marco; Santoro, Armando; Prat, Aleix; Tabernero, Josep; Hemelrijck, Mieke van; Diamantis, Nikolaos; Gennari, Alessandra und Cortellini, Alessio
(2021):
Time-Dependent COVID-19 Mortality in Patients With Cancer An Updated Analysis of the OnCovid Registry.
In: Jama Oncology, Bd. 8, Nr. 1: S. 114-122
Pinato, David J.; Tabernero, Josep; Bower, Mark; Scotti, Lorenza; Patel, Meera; Colomba, Emeline; Dolly, Saoirse; Loizidou, Angela; Chester, John; Mukherjee, Uma; Zambelli, Alberto; Dalla Pria, Alessia; Aguilar-Company, Juan; Ottaviani, Diego; Chowdhury, Amani; Merry, Eve; Salazar, Ramon; Bertuzzi, Alexia; Brunet, Joan; Lambertini, Matteo; Tagliamento, Marco; Pous, Anna; Sita-Lumsden, Ailsa; Srikandarajah, Krishnie; Colomba, Johann; Pommeret, Fanny; Segui, Elia; Generali, Daniele; Grisanti, Salvatore; Pedrazzoli, Paolo; Rizzo, Gianpiero; Libertini, Michela; Moss, Charlotte; Evans, Joanne S.; Russell, Beth; Harbeck, Nadia; Vincenzi, Bruno; Biello, Federica; Bertulli, Rossella; Linan, Raquel; Rossi, Sabrina; Carmona-Garcia, Maria Carmen; Tondini, Carlo; Fox, Laura; Baggi, Alice; Fotia, Vittoria; Parisi, Alessandro; Porzio, Giampero; Saponara, Maristella; Cruz, Claudia Andrea; Garcia-Illescas, David; Felip, Eudald; Lloveras, Ariadna Roque; Sharkey, Rachel; Roldan, Elisa; Reyes, Roxana; Earnshaw, Irina; Ferrante, Daniela; Marco-Hernandez, Javier; Ruiz-Camps, Isabel; Gaidano, Gianluca; Patriarca, Andrea; Bruna, Riccardo; Sureda, Anna; Martinez-Vila, Clara; Sanchez de Torre, Ana; Cantini, Luca; Filetti, Marco; Rimassa, Lorenza; Chiudinelli, Lorenzo; Franchi, Michela; Krengli, Marco; Santoro, Armando; Prat, Aleix; Hemelrijck, Mieke van; Diamantis, Nikolaos; Newsom-Davis, Thomas; Gennari, Alessandra und Cortellini, Alessio
(2021):
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study.
In: Lancet Oncology, Bd. 22, Nr. 12: S. 1669-1680
Pizzamiglio, Sara; Ciniselli, Chiara Maura; Triulzi, Tiziana; Gargiuli, Chiara; De Cecco, Loris; de Azambuja, Evandro; Fumagalli, Debora; Sotiriou, Christos; Harbeck, Nadia; Izquierdo, Miguel; Nuciforo, Paolo; Huober, Jens; Cappelletti, Vera; Cinieri, Saverio; Piccart, Martine; Daidone, Maria Grazia; Pruneri, Giancarlo; Colombo, Mario Paolo; Tagliabue, Elda; Verderio, Paolo und Di Cosimo, Serena
(2021):
Integrated Molecular and Immune Phenotype of HER2-Positive Breast Cancer and Response to Neoadjuvant Therapy: A NeoALTTO Exploratory Analysis.
In: Clinical Cancer Research, Bd. 27, Nr. 23: S. 6307-6313
Schettini, Francesco; Giuliano, Mario; Lambertini, Matteo; Bartsch, Rupert; Pinato, David James; Onesti, Concetta Elisa; Harbeck, Nadia; Lueftner, Diana; Rottey, Sylvie; Dam, Peter A. van; Zaman, Khalil; Mustacchi, Giorgio; Gligorov, Joseph; Awada, Ahmad; Campone, Mario; Wildiers, Hans; Gennari, Alessandra; Tjan-Heijnen, Vivianne C. G.; Cortes, Javier; Locci, Mariavittoria; Paris, Ida; Del Mastro, Lucia; De Placido, Sabino; Martin, Miguel; Jerusalem, Guy; Venturini, Sergio; Curigliano, Giuseppe und Generali, Daniele
(2021):
Anthracyclines Strike Back: Rediscovering Non-Pegylated Liposomal Doxorubicin in Current Therapeutic Scenarios of Breast Cancer.
In: Cancers, Bd. 13, Nr. 17, 4421
Schneeweiss, Andreas; Huober, Jens; Brucker, Sara Y.; Budach, Wilfried; Denkert, Carsten; Fasching, Peter A.; Haidinger, Renate; Harbeck, Nadia; Jackisch, Christian; Janni, Wolfgang; Krug, David; Kuehn, Thorsten; Loibl, Sibylle; Mueller, Volkmar; Thill, Marc; Thomssen, Christoph; Untch, Michael; Kolberg-Liedtke, Cornelia und Lueftner, Diana
(2021):
Frühes Mammakarzinom: Aktuelle Strategien in der System- und Radiotherapie. 17. Internationale St.-Gallen-Konsensuskonferenz vor dem Hintergrund deutscher Therapieempfehlungen diskutiert.
In: Onkologe, Bd. 27, Nr. 8: S. 820-830
Shao, Wanting; Kuhn, Christina; Mayr, Doris; Ditsch, Nina; Kailuwait, Magdalena; Wolf, Verena; Harbeck, Nadia; Mahner, Sven; Jeschke, Udo; Cavailles, Vincent und Sixou, Sophie
(2021):
Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer.
In: Journal of Cancer Research and Clinical Oncology, Bd. 147, Nr. 9: S. 2535-2544
Stoetzer, Oliver; Di Gioia, Dorit; Issels, Rolf Dieter; Abdel-Rahman, Sultan; Mansmann, Ulrich; Lindner, Lars Hartwin; Gluz, Oleg; Würstlein, Rachel; Braun, Michael; Hamann, Moritz; von Koch, Franz Edler; Harbeck, Nadia und Salat, Christoph
(2021):
Post-Neoadjuvant Gemcitabine and Cisplatin with Regional Hyperthermia for Patients with Triple-Negative Breast Cancer and Non-pCR after Neoadjuvant Chemotherapy: A Single-Institute Experience.
In: Breast Care, Bd. 16, Nr. 2: S. 173-180
Sultova, Elena; Westphalen, C. Benedikt; Jung, Andreas; Kumbrink, Jörg; Kirchner, Thomas; Mayr, Doris; Rudelius, Martina; Ormanns, Steffen; Heinemann, Volker; Metzeler, Klaus H.; Greif, Philipp A.; Hester, Anna; Mahner, Sven; Harbeck, Nadia und Würstlein, Rachel
(2021):
Implementation of Precision Oncology for Patients with Metastatic Breast Cancer in an Interdisciplinary MTB Setting.
In: Diagnostics, Bd. 11, Nr. 4, 733
Thomssen, Christoph; Balic, Marija; Harbeck, Nadia und Gnant, Michael
(2021):
St. Gallen/Vienna 2021: A Brief Summary of the Consensus Discussion on Customizing Therapies for Women with Early Breast Cancer.
In: Breast Care, Bd. 16, Nr. 2: S. 135-143
Untch, Michael; Fasching, Peter A.; Brucker, Sara Y.; Budach, Wilfried; Denkert, Carsten; Haidinger, Renate; Huober, Jens; Jackisch, Christian; Janni, Wolfgang; Kolberg-Liedtke, Cornelia; Krug, David; Kuehn, Thorsten; Loibl, Sibylle; Lueftner, Diana; Mueller, Volkmar; Schneeweiss, Andreas; Thill, Marc; Harbeck, Nadia und Thomssen, Christoph
(2021):
Behandlung von Patientinnen mit frühem Mammakarzinom: Evidenz, Kontroversen, Konsens. Meinungsbild deutscher Expert*Innen zur 17. Internationalen St.-Gallen-Konsensuskonferenz.
In: Geburtshilfe und Frauenheilkunde, Bd. 81, Nr. 6: S. 637-653
Vathiotis, Ioannis A.; Moutafi, Myrto K.; Divakar, Prajan; Aung, Thazin Nwe; Qing, Tao; Fernandez, Aileen; Yaghoobi, Vesal; El-Abed, Sarra; Wang, Yingbo; Guillaume, Sebastien; Nuciforo, Paolo; Huober, Jens; Di Cosimo, Serena; Kim, Sung-Bae; Harbeck, Nadia; Gomez, Henry; Shafi, Saba; Syrigos, Konstantinos N.; Fountzilas, George; Sotiriou, Christos; Pusztai, Lajos; Warren, Sarah und Rimm, David L.
(2021):
Alpha-smooth Muscle Actin Expression in the Stroma Predicts Resistance to Trastuzumab in Patients with Early-stage HER2-positive Breast Cancer.
In: Clinical Cancer Research, Bd. 27, Nr. 22: S. 6156-6163
Venet, David; Rediti, Mattia; Maetens, Marion; Fumagalli, Debora; Brown, David N.; Majjaj, Samira; Salgado, Roberto; Pusztai, Lajos; Harbeck, Nadia; El-Abed, Sarra; Wang, Yingbo; Saura, Cristina; Gomez, Henry; Semiglazov, Vladimir Fedorovich; de Azambuja, Evandro; Huober, Jens; Nuciforo, Paolo; Di Cosimo, Serena; Piccart, Martine; Loi, Sherene; Rothe, Francoise und Sotiriou, Christos
(2021):
Copy Number Aberration Analysis to Predict Response to Neoadjuvant Anti-HER2 Therapy: Results from the NeoALTTO Phase III Clinical Trial.
In: Clinical Cancer Research, Bd. 27, Nr. 20: S. 5607-5618
Winer, Eric P.; Lipatov, Oleg; Im, Seock-Ah; Goncalves, Anthony; Munoz-Couselo, Eva; Lee, Keun Seok; Schmid, Peter; Tamura, Kenji; Testa, Laura; Witzel, Isabell; Ohtani, Shoichiro; Turner, Nicholas; Zambelli, Stefania; Harbeck, Nadia; Andre, Fabrice; Dent, Rebecca; Zhou, Xuan; Karantza, Vassiliki; Mejia, Jaime und Cortes, Javier
(2021):
Pembrolizumab versus investigator-choice chemotherapy for metastatic triple-negative breast cancer (KEYNOTE-119): a randomised, open-label, phase 3 trial.
In: Lancet Oncology, Bd. 22, Nr. 4: S. 499-511
Wuerstlein, Rachel; Harbeck, Nadia; Grischke, Eva-Maria; Forstmeyer, Dirk; Schumann, Raquel von; Krabisch, Petra; Ludtke-Heckenkamp, Kerstin; Stefek, Andrea; Stoetzer, Oliver; Grafe, Andrea; Kaltenecker, Gabriele; Forstbauer, Helmut; Augustin, Doris; Schrader, Iris; Tio, Joke; Nitz, Ulrike; Gluz, Oleg; Kates, Ronald E. und Graeser, Monika Karla
(2021):
Protroca: A Noninterventional Study on Prophylactic Lipegfilgrastim against Chemotherapy-Induced Neutropenia in Nonselected Breast Cancer Patients.
In: Breast Care, Bd. 16, Nr. 1: S. 50-58
Huber, Marinus; Kepesidis, Kosmas V.; Voronina, Liudmila; Božić, Maša; Trubetskov, Michael; Harbeck, Nadia; Krausz, Ferenc ORCID: https://orcid.org/0000-0002-6525-9449 und Žigman, Mihaela
(2021):
Stability of person-specific blood-based infrared molecular fingerprints opens up prospects for health monitoring.
In: Nature Communications, Bd. 12, 1511
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-6525-9449 und Žigman, Mihaela
(2021):
Stability of person-specific blood-based infrared molecular fingerprints opens up prospects for health monitoring.
In: Nature Communications, Bd. 12, 1511
[PDF, 1MB]
Sultova, Elena; Westphalen, C. Benedikt; Jung, Andreas; Kumbrink, Joerg; Kirchner, Thomas; Mayr, Doris; Rudelius, Martina; Ormanns, Steffen; Heinemann, Volker; Metzeler, Klaus H.; Greif, Philipp A.; Burges, Alexander; Trillsch, Fabian; Mahner, Sven; Harbeck, Nadia und Wuerstlein, Rachel
(2021):
NGS-guided precision oncology in metastatic breast and gynecological cancer: first experiences at the CCC Munich LMU.
In: Archives of gynecology and obstetrics, Bd. 303, Nr. 5: S. 1331-1345
[PDF, 1MB]
Stoetzer, Oliver; Di Gioia, Dorit; Harbeck, Nadia; Salat, Christoph; Mansmann, Ulrich ORCID: https://orcid.org/0000-0002-9955-8906; Harbeck, Nadia; Würstlein, Rachel; Edler von Koch, Franz; Hamann, M.; Braun, M.; Gluz, O.; Lindner, Lars H.; Abdel-Rahman, Sultan und Issels, Rolf D.
(2021):
Post-Neoadjuvant Gemcitabine and Cisplatin with Regional Hyperthermia for Patients with Triple-Negative Breast Cancer and Non-pCR after Neoadjuvant Chemotherapy: A Single-Institute Experience.
In: Breast Care, Bd. 16, Nr. 2: S. 173-180
ORCID: https://orcid.org/0000-0002-9955-8906; Harbeck, Nadia; Würstlein, Rachel; Edler von Koch, Franz; Hamann, M.; Braun, M.; Gluz, O.; Lindner, Lars H.; Abdel-Rahman, Sultan und Issels, Rolf D.
(2021):
Post-Neoadjuvant Gemcitabine and Cisplatin with Regional Hyperthermia for Patients with Triple-Negative Breast Cancer and Non-pCR after Neoadjuvant Chemotherapy: A Single-Institute Experience.
In: Breast Care, Bd. 16, Nr. 2: S. 173-180
Shao, Wanting; Kuhn, Christina; Mayr, Doris; Ditsch, Nina; Kailuwait, Magdalena; Wolf, Verena; Harbeck, Nadia; Mahner, Sven; Jeschke, Udo; Cavaillès, Vincent und Sixou, Sophie
(2020):
Cytoplasmic PPARγ is a marker of poor prognosis in patients with Cox-1 negative primary breast cancers.
In: Journal of Translational Medicine
18:94
[PDF, 1MB]
Christgen, Matthias; Gluz, Oleg; Harbeck, Nadia; Kates, Ronald E.; Raap, Mieke; Christgen, Henriette; Clemens, Michael; Malter, Wolfram; Nuding, Benno; Aktas, Bahriye; Kuemmel, Sherko; Reimer, Toralf; Stefek, Andrea; Krabisch, Petra; Just, Marianne; Augustin, Doris; Graeser, Monika; Baehner, Frederick; Würstlein, Rachel; Nitz, Ulrike und Kreipe, Hans
(2020):
Differential impact of prognostic parameters in hormone receptor-positive lobular breast cancer.
In: Cancer, Bd. 126, Nr. 22: S. 4847-4858
Gluz, Oleg; Kolberg-Liedtke, Cornelia; Prat, Aleix; Christgen, Matthias; Gebauer, Daniel; Kates, Ronald; Pare, Laia; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Kuemmel, Sherko; Würstlein, Rachel; Pelz, Enrico; Nitz, Ulrike; Kreipe, Hans Heinrich und Harbeck, Nadia
(2020):
Efficacy of deescalated chemotherapy according to PAM50 subtypes, immune and proliferation genes in triple-negative early breast cancer: Primary translational analysis of the WSG-ADAPT-TN trial.
In: International Journal of Cancer, Bd. 146, Nr. 1: S. 262-271
Sonnenblick, Amir; Agbor-tarh, Dominique; de Azambuja, Evandro; Hultsch, Susanne; Izquierdo, Miguel; Liu, Minetta; Pruneri, Giancarlo; Harbeck, Nadia; Piccart, Martine; Moreno-Aspita, Alvaro; Granit, Roy Zvi; Rouas, Ghizlane; Fahoum, Ibrahim und Sotiriou, Christos
(2020):
STAT3 activation in HER2-positive breast cancers: Analysis of data from a large prospective trial.
In: International Journal of Cancer, Bd. 148, Nr. 6: S. 1529-1535
Bekes, Inga; Eichler, Martin; Singer, Susanne; Friedl, Thomas W. P.; Harbeck, Nadia; Rack, Brigitte; Forstbauer, Helmut; Dannecker, Christian; Huober, Jens; Kiechle, Marion; Lato, Krisztian; Janni, Wolfgang und Fink, Visnja
(2020):
Impact of Granulocyte Colony-Stimulating Factor (G-CSF) and Epoetin (EPO) on Hematologic Toxicities and Quality of Life in Patients During Adjuvant Chemotherapy in Early Breast Cancer: Results From the Multi-Center Randomized ADEBAR Trial.
In: Clinical Breast Cancer, Bd. 20, Nr. 6: S. 439-447
Mittendorf, Elizabeth A.; Zhang, Hong; Barrios, Carlos H.; Saji, Shigehira; Jung, Kyung Hae; Hegg, Roberto; Koehler, Andreas; Sohn, Joohyuk; Iwata, Hiroji; Telli, Melinda L.; Ferrario, Cristiano; Punie, Kevin; Penault-Llorca, Frederique; Patel, Shilpen; Anh Nguyen, Duc; Liste-Hermoso, Mario; Maiya, Vidya; Molinero, Luciana; Chui, Stephen Y. und Harbeck, Nadia
(2020):
Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial.
In: Lancet, Bd. 396, Nr. 10257: S. 1090-1100
Werner-Klein, Melanie; Grujovic, Ana; Irlbeck, Christoph; Hoffmann, Martin; Koerkel-Qu, Huiqin; Lu, Xin; Treitschke, Steffi; Koestler, Cacilia; Botteron, Catherine; Weidele, Kathrin; Werno, Christian; Polzer, Bernhard; Kirsch, Stefan; Guzvic, Miodrag; Warfsmann, Jens; Honarnejad, Kamran; Czyz, Zbigniew; Feliciello, Giancarlo; Blochberger, Isabell; Grunewald, Sandra; Schneider, Elisabeth; Haunschild, Gundula; Patwary, Nina; Guetter, Severin; Huber, Sandra; Rack, Brigitte; Harbeck, Nadia; Buchholz, Stefan; Rümmele, Petra; Heine, Norbert; Rose-John, Stefan und Klein, Christoph A.
(2020):
Interleukin-6 trans-signaling is a candidate mechanism to drive progression of human DCCs during clinical latency.
In: Nature Communications, Bd. 11, Nr. 1, 4977
[PDF, 2MB]
Dowsett, Mitch; Ellis, Matthew J. ORCID: https://orcid.org/0000-0002-8467-8534; Dixon, J. Michael; Gluz, Oleg; Robertson, John; Kates, Ronald; Suman, Vera J.; Turnbull, Arran K.; Nitz, Ulrike; Christgen, Matthias; Kreipe, Hans; Kuemmel, Sherko; Bliss, Judith M.; Barry, Peter; Johnston, Stephen R.; Jacobs, Samuel A.; Ma, Cynthia X.; Smith, Ian E. und Harbeck, Nadia ORCID: https://orcid.org/0000-0002-9744-7372
(2020):
Evidence-based guidelines for managing patients with primary ER+ HER2- breast cancer deferred from surgery due to the COVID-19 pandemic.
In: Npj Breast Cancer, Bd. 6, Nr. 1, 21: S. 1-10
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-8467-8534; Dixon, J. Michael; Gluz, Oleg; Robertson, John; Kates, Ronald; Suman, Vera J.; Turnbull, Arran K.; Nitz, Ulrike; Christgen, Matthias; Kreipe, Hans; Kuemmel, Sherko; Bliss, Judith M.; Barry, Peter; Johnston, Stephen R.; Jacobs, Samuel A.; Ma, Cynthia X.; Smith, Ian E. und Harbeck, Nadia ORCID: https://orcid.org/0000-0002-9744-7372
(2020):
Evidence-based guidelines for managing patients with primary ER+ HER2- breast cancer deferred from surgery due to the COVID-19 pandemic.
In: Npj Breast Cancer, Bd. 6, Nr. 1, 21: S. 1-10
[PDF, 1MB]
Hester, Anna; Gass, Paul; Fasching, Peter A.; Kraemer, Anne Katrin; Ettl, Johannes; Diessner, Joachim; Woeckel, Achim; Egger, Tobias; Stock, Katja; Redlin, Jutta; Andraschko, Monika; Harbeck, Nadia und Würstlein, Rachel
(2020):
Trastuzumab Biosimilars in the Therapy of Breast Cancer - "Real World" Experiences from four Bavarian University Breast Centres.
In: Geburtshilfe und Frauenheilkunde, Bd. 80, Nr. 09: S. 924-931
Schmid, Peter; Cortes, Javier; Pusztai, Lajos; McArthur, Heather; Kuemmel, Sherko; Bergh, Jonas; Denkert, Carsten; Park, Yeon Hee; Hui, Rina; Harbeck, Nadia; Takahashi, Masato; Foukakis, Theodoros; Fasching, Peter A.; Cardoso, Fatima; Untch, Michael; Jia, Liyi; Karantza, Vassiliki; Zhao, Jing; Aktan, Gursel; Dent, Rebecca und O'Shaughnessy, Joyce
(2020):
Pembrolizumab for Early Triple-Negative Breast Cancer.
In: New England Journal of Medicine, Bd. 382, Nr. 9: S. 810-821
Onesti, Concetta Elisa; Rugo, Hope S.; Generali, Daniele; Peeters, Marc; Zaman, Khalil; Wildiers, Hans; Harbeck, Nadia; Martin, Miguel; Cristofanilli, Massimo; Cortes, Javier; Tjan-Heijnen, Vivianne; Hurvitz, Sara A.; Berchem, Guy; Tagliamento, Marco; Campone, Mario; Bartsch, Rupert; De Placido, Sabino; Puglisi, Fabio; Rottey, Sylvie; Müller, Volkmar; Ruhstaller, Thomas; Machiels, Jean-Pascal; Conte, PierFranco; Awada, Ahmad und Jerusalem, Guy
(2020):
Oncological care organisation during COVID-19 outbreak.
In: Esmo Open, Bd. 5, Nr. 4, e000853
Finn, Richard S.; Liu, Yuan; Zhu, Zhou; Martin, Miguel; Rugo, Hope S.; Dieras, Veronique; Im, Seock-Ah; Gelmon, Karen A.; Harbeck, Nadia; Lu, Dongrui R.; Gauthier, Eric; Bartlett, Cynthia Huang und Slamon, Dennis J.
(2020):
Biomarker Analyses of Response to Cyclin-Dependent Kinase 4/6 Inhibition and Endocrine Therapy in Women with Treatment-Naive Metastatic Breast Cancer.
In: Clinical Cancer Research, Bd. 26, Nr. 1: S. 110-121
Robertson, John F. R.; Evans, Abigail; Henschen, Stephan; Kirwan, Cliona C.; Jahan, Ali; Kenny, Laura M.; Dixon, J. Michael; Schmid, Peter; Kothari, Ashutosh; Mohamed, Omar; Fasching, Peter A.; Cheung, Kwok-Leung; Würstlein, Rachel; Carroll, Danielle; Klinowska, Teresa; Lindemann, Justin P. O.; MacDonald, Alexander; Mather, Richard; Maudsley, Rhiannon; Moschetta, Michele; Nikolaou, Myria; Roudier, Martine P.; Sarvotham, Tinnu; Schiavon, Gaia; Zhou, Diansong; Zhou, Li und Harbeck, Nadia
(2020):
A Randomized, Open-label, Presurgical, Window-of-Opportunity Study Comparing the Pharmacodynamic Effects of the Novel Oral SERD AZD9496 with Fulvestrant in Patients with Newly Diagnosed ER+ HER2(-) Primary Breast Cancer.
In: Clinical Cancer Research, Bd. 26, Nr. 16: S. 4242-4249
Pinato, David J.; Zambelli, Alberto; Aguilar-Company, Juan; Bower, Mark; Sng, Christopher C. T.; Salazar, Ramon; Bertuzzi, Alexia; Brunet, Joan; Mesia, Ricard; Segui, Elia; Biello, Federica; Generali, Daniele; Grisanti, Salvatore; Rizzo, Gianpiero; Libertini, Michela; Maconi, Antonio; Harbeck, Nadia; Vincenzi, Bruno; Bertulli, Rossella; Ottaviani, Diego; Carbo, Anna; Bruna, Riccardo; Benafif, Sarah; Marrari, Andrea; Würstlein, Rachel; Carmona-Garcia, M. Carmen; Chopra, Neha; Tondini, Carlo; Mirallas, Oriol; Tovazzi, Valeria; Betti, Marta; Provenzano, Salvatore; Fotia, Vittoria; Cruz, Claudia Andrea; Dalla Pria, Alessia; D'Avanzo, Francesca; Evans, Joanne S.; Saoudi-Gonzalez, Nadia; Felip, Eudald; Galazi, Myria; Garcia-Fructuoso, Isabel; Lee, Alvin J. X.; Newsom-Davis, Thomas; Patriarca, Andrea; Garcia-Illescas, David; Reyes, Roxana; Dileo, Palma; Sharkey, Rachel; Wong, Yien Ning Sophia; Ferrante, Daniela; Marco-Hernandez, Javier; Sureda, Anna; Maluquer, Clara; Ruiz-Camps, Isabel; Gaidano, Gianluca; Rimassa, Lorenza; Chiudinelli, Lorenzo; Izuzquiza, Macarena; Cabirta, Alba; Franchi, Michela; Santoro, Armando; Prat, Aleix; Tabernero, Josep und Gennari, Alessandra
(2020):
Clinical Portrait of the SARS-CoV-2 Epidemic in European Patients with Cancer.
In: Cancer Discovery, Bd. 10, Nr. 10: S. 1465-1474
Jackisch, Christian; Kreienberg, Rolf; Blettner, Maria; Harbeck, Nadia; Lueck, Hans-Joachim; Haidinger, Renate; Schmitt, Doris C.; Schulte, Hilde; Windemuth-Kieselbach, Christine; Zaun, Silke und Hadji, Peyman
(2020):
Assessment of Quality of Life in Postmenopausal Women with Early Breast Cancer Participating in the PACT Trial: The Impact of Additional Patient Information Material Packages and Patient Compliance.
In: Breast Care, Bd. 15, Nr. 3: S. 236-245
Bitto, Franz-Ferdinand; König, Alexander; Phan-Brehm, Thuy; Vallbracht, Thomas; Koch, Julian Gregor; Schinkoethe, Timo; Wolfgarten, Matthias; Mahner, Sven; Harbeck, Nadia und Würstlein, Rachel
(2020):
EVA-Scalp: Evaluation of Patient Satisfaction with a Scalp Cooling Device to Prevent Chemotherapy-Induced Alopecia in Breast Cancer Patients.
In: Breast Care, Bd. 15, Nr. 2: S. 171-177
Kolben, Thomas; Bardenhewer, Maximilian; Kolben, Theresa M.; Rickerl, Laura; Degenhardt, Tom; Mahner, Sven; Harbeck, Nadia und Würstlein, Rachel
(2020):
Metastatic Breast Cancer: Is There a Differential Therapy Efficacy between Visceral and Non-Visceral Metastatic Breast Cancer?
In: Breast Care, Bd. 15, Nr. 5: S. 527-533
Thomssen, Christoph; Lueftner, Diana; Untch, Michael; Haidinger, Renate; Würstlein, Rachel; Harbeck, Nadia; Augustin, Doris; Briest, Susanne; Ettl, Johannes; Fasching, Peter A.; Foerster, Frank; Kurbacher, Christian M.; Lueck, Hans-Joachim; Marschner, Norbert; Müller, Lothar; Müller, Volkmar; Perlova-Griff, Lidia; Radke, Isabel; Ruckhaeberle, Eugen; Scheffen, Iris; Schumacher-Wulf, Eva; Schwoerer, Moritz; Steinfeld-Birg, Dieter und Ziegler-Loehr, Katja
(2020):
International Consensus Conference for Advanced Breast Cancer, Lisbon 2019: ABC5 Consensus - Assessment by a German Group of Experts.
In: Breast Care, Bd. 15, Nr. 1: S. 82-95
Ditsch, Nina; Untch, Michael; Kolberg-Liedtke, Cornelia; Jackisch, Christian; Krug, David; Friedrich, Michael; Janni, Wolfgang; Müller, Volkmar; Albert, Ute-Susann; Banys-Paluchowski, Malgorzata; Bauerfeind, Ingo; Blohmer, Jens-Uwe; Budach, Wilfried; Dall, Peter; Diel, Ingo; Fallenberg, Eva Maria; Fasching, Peter A.; Fehm, Tanja; Gerber, Bernd; Gluz, Oleg; Hanf, Volker; Harbeck, Nadia; Heil, Jörg; Huober, Jens; Kreipe, Hans H.; Kuehn, Thorsten; Kuemmel, Sherko; Loibl, Sibylle; Lueftner, Diana; Lux, Michael; Maass, Nicolai; Moebus, Volker; Mundhenke, Christoph; Park-Simon, Tjoung-Won; Reimer, Toralf; Rhiem, Kerstin; Rody, Achim; Schmidt, Marcus; Schneeweiss, Andreas; Solbach, Chistine; Solomayer, Erich-Franz; Stickeler, Elmar; Thomssen, Christoph; Witzel, Isabell; Woeckel, Achim und Thill, Marc
(2020):
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2020.
In: Breast Care, Bd. 15, Nr. 3: S. 294-309
Kolberg-Liedtke, Cornelia; Würstlein, Rachel; Gluz, Oleg; Heitz, Florian; Freudenberger, Muriel; Bensmann, Elena; du Bois, Andreas; Nitz, Ulrike; Pelz, Enrico; Warm, Matthias; Ortmann, Monika; Sultova, Elena; Brucker, Sara Y.; Kates, Ronald E.; Fehm, Tanja und Harbeck, Nadia
(2020):
Phenotype Discordance between Primary Tumor and Metastasis Impacts Metastasis Site and Outcome: Results of WSG-DETECT-PriMet.
In: Breast Care
Harbeck, Nadia; Franke, Fabio; Villanueva-Vazquez, Rafael; Lu, Yen-Shen; Tripathy, Debu; Chow, Louis; Babu, Govind K.; Im, Young-Hyuck; Chandiwana, David; Gaur, Anil; Lanoue, Brad; Rodriguez-Lorenc, Karen und Bardia, Aditya
(2020):
Health-related quality of life in premenopausal women with hormone-receptor-positive, HER2-negative advanced breast cancer treated with ribociclib plus endocrine therapy: results from a phase III randomized clinical trial (MONALEESA-7).
In: Therapeutic Advances in Medical Oncology, Bd. 12: S. 1-8
[PDF, 766kB]
Nitz, Ulrike; Gluz, Oleg; Kreipe, Hans H.; Christgen, Matthias; Kuemmel, Sherko; Baehner, Frederick L.; Shak, Steven; Aktas, Bahriye; Braun, Michael; Ludtke-Heckenkamp, Kerstin; Forstbauer, Helmut; Grischke, Eva-Maria; Nuding, Benno; Darsow, Maren; Schumacher, Claudia; Krauss, Katja; Malter, Wolfram; Thill, Marc; Warm, Mathias; Würstlein, Rachel; Kates, Ronald E. und Harbeck, Nadia
(2020):
The run-in phase of the prospective WSG-ADAPT HR+/HER2-trial demonstrates the feasibility of a study design combining static and dynamic biomarker assessments for individualized therapy in early breast cancer.
In: Therapeutic Advances in Medical Oncology, Bd. 12: S. 1-9
[PDF, 531kB]
Gaasch, Aurelie; Schönecker, Stephan; Simonetto, Cristoforo; Eidemüller, Markus; Pazos, Montserrat; Reitz, Daniel; Rottler, Maya; Freislederer, Philipp; Braun, Michael; Würstlein, Rachel; Harbeck, Nadia; Niyazi, Maximilian; Belka, Claus und Corradini, Stefanie
(2020):
Heart sparing radiotherapy in breast cancer: the importance of baseline cardiac risks.
In: Radiation Oncology, Bd. 15, Nr. 1, 117
Kolberg-Liedtke, Cornelia; Gluz, Oleg; Heinisch, Fred; Feuerhake, Friedrich; Kreipe, Hans; Clemens; Nuding, Benno; Malter, Wolfram; Reimer, Tora; Würstlein, Rachel; Graeser, Monika; Shak, Steve; Nitz, Ulrike; Kates, Ronald; Christgen, Matthias und Harbeck, Nadia
(2020):
Association of TILs with clinical parameters, Recurrence Score (R) results, and prognosis in patients with early HER2-negative breast cancer (BC)-a translational analysis of the prospective WSG PlanB trial.
In: Breast Cancer Research, Bd. 22, Nr. 1, 47
Johnston, Stephen R. D.; Harbeck, Nadia; Hegg, Roberto; Toi, Masakazu; Martin, Miguel; Shao, Zhi Min; Zhang, Qing Yuan; Martinez Rodriguez, Jorge Luis; Campone, Mario; Hamilton, Erika; Sohn, Joohyuk; Guarneri, Valentina; Okada, Morihito; Boyle, Frances; Neven, Patrick; Cortes, Javier; Huober, Jens; Wardley, Andrew; Tolaney, Sara M.; Cicin, Irfan; Smith, Ian C.; Frenzel, Martin; Headley, Desiree; Wei, Ran; San Antonio, Belen; Hulstijn, Maarten; Cox, Joanne; O'Shaughnessy, Joyce und Rastogi, Priya
(2020):
Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE).
In: Journal of Clinical Oncology, Bd. 38, Nr. 34
Cortes, Javier; Perez-Garcia, Jose Manuel; Llombart-Cussac, Antonio; Curigliano, Giuseppe; El Saghir, Nagi S.; Cardoso, Fatima; Barrios, Carlos H.; Wagle, Shama; Roman, Javier; Harbeck, Nadia; Eniu, Alexandru; Kaufman, Peter A.; Tabernero, Josep; Garcia-Estevez, Laura; Schmid, Peter und Arribas, Joaquin
(2020):
Enhancing global access to cancer medicines.
In: CA : A Cancer Journal for Clinicians, Bd. 70, Nr. 2: S. 105-124
Griguolo, Gaia; Braso-Maristany, Fara; Gonzalez-Farre, Blanca; Pascual, Tomas; Chic, Nuria; Sauri, Tamara; Kates, Ronald; Gluz, Oleg; Martinez, Debora; Pare, Laia; Tsvetkova, Vassilena; Pesantez, David; Vidal, Maria; Adamo, Barbara; Munoz, Montserrat; Galvan, Patricia; Barbera, Laura; Cuatrecasas, Miriam; Christgen, Mathias; Kreipe, Hans; Monge-Escartin, Ines; Villagrasa, Patricia; Soy, Dolors; Giarratano, Tommaso; Dieci, Maria Vittoria; Conte, Pierfranco; Harbeck, Nadia; Guarneri, Valentina und Prat, Aleix
(2020):
ERBB2mRNA Expression and Response to Ado-Trastuzumab Emtansine (T-DM1) in HER2-Positive Breast Cancer.
In: Cancers, Bd. 12, Nr. 7, 1902
Shao, Wanting; Kuhn, Christina; Mayr, Doris; Ditsch, Nina; Kailuweit, Magdalena; Wolf, Verena; Harbeck, Nadia; Mahner, Sven; Jeschke, Udo; Cavailles, Vincent und Sixou, Sophie
(2020):
Cytoplasmic and Nuclear Forms of Thyroid Hormone Receptor beta 1 Are Inversely Associated with Survival in Primary Breast Cancer.
In: International Journal of Molecular Sciences, Bd. 21, Nr. 1, 330
Gonzalez-Ericsson, Paula I.; Stovgaard, Elisabeth S.; Sua, Luz F.; Reisenbichler, Emily; Kos, Zuzana; Carter, Jodi M.; Michiels, Stefan; Le Quesne, John; Nielsen, Torsten O.; Laenkholm, Anne-Vibeke; Fox, Stephen B.; Adam, Julien; Bartlett, John M. S.; Rimm, David L.; Quinn, Cecily; Peeters, Dieter; Dieci, Maria V.; Vincent-Salomon, Anne; Cree, Ian; Hida, Akira I.; Balko, Justin M.; Haynes, Harry R.; Frahm, Isabel; Acosta-Haab, Gabriela; Balancin, Marcelo; Bellolio, Enrique; Yang, Wentao; Kirtani, Pawan; Sugie, Tomoharu; Ehinger, Anna; Castaneda, Carlos A.; Kok, Marleen; McArthur, Heather; Siziopikou, Kalliopi; Badve, Sunil; Fineberg, Susan; Gown, Allen; Viale, Giuseppe; Schnitt, Stuart J.; Pruneri, Giancarlo; Penault-Llorca, Frederique; Hewitt, Stephen; Thompson, E. Aubrey; Allison, Kimberly H.; Symmans, William F.; Bellizzi, Andrew M.; Brogi, Edi; Moore, David A.; Larsimont, Denis; Dillon, Deborah A.; Lazar, Alexander; Lien, Huangchun; Goetz, Matthew P.; Broeckx, Glenn; El Bairi, Khalid; Harbeck, Nadia; Cimino-Mathews, Ashley; Sotiriou, Christos; Adams, Sylvia; Liu, Shi-Wei; Loibl, Sibylle; Chen, I-Chun; Lakhani, Sunil R.; Juco, Jonathan W.; Denkert, Carsten; Blackley, Elizabeth F.; Demaria, Sandra; Leon-Ferre, Roberto; Gluz, Oleg; Zardavas, Dimitrios; Emancipator, Kenneth; Ely, Scott; Loi, Sherene; Salgado, Roberto und Sanders, Melinda
(2020):
The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice.
In: Journal of Pathology, Bd. 250, Nr. 5: S. 667-684
Untch, Michael; Würstlein, Rachel; Lueftner, Diana; Haidinger, Renate; Fasching, Peter A.; Augustin, Doris; Briest, Susanne; Ettl, Johannes; Foerster, Frank; Kurbacher, Christian M.; Lueck, Hans-Joachim; Marschner, Norbert; Müller, Lothar; Müller, Volkmar; Radke, Isabel; Ruckhaeberle, Eugen; Scheffen, Iris; Schumacher-Wulf, Eva; Schwoerer, Moritz; Steinfeld-Birg, Dieter; Ziegler-Loehr, Katja; Thomssen, Christoph und Harbeck, Nadia
(2020):
ABC5 International Consensus Conference on Advanced Breast Cancer, Lisbon, 16 November 2019 Commentary by the German panel of experts on the ABC5 voting results.
In: Geburtshilfe und Frauenheilkunde, Bd. 80, Nr. 06: S. 588-600
Jeschke, Udo; Zhang, Xi; Kuhn, Christina; Jalaguier, Stephan; Colinge, Jacques; Pfender, Kristina; Mayr, Doris; Ditsch, Nina; Harbeck, Nadia; Mahner, Sven; Sixou, Sophie und Cavailles, Vincent
(2019):
The Prognostic Impact of the Aryl Hydrocarbon Receptor (AhR) in Primary Breast Cancer Depends on the Lymph Node Status.
In: International Journal of Molecular Sciences, Bd. 20, Nr. 5, 1016
Corradini, Stefanie; Reitz, Daniel; Pazos, Montserrat; Schönecker, Stephan; Braun, Michael; Harbeck, Nadia; Matuschek, Christiane; Boelke, Edwin; Ganswindt, Ute; Alongi, Filippo; Niyazi, Maximilian und Belka, Claus
(2019):
Mastectomy or Breast-Conserving Therapy for Early Breast Cancer in Real-Life Clinical Practice: Outcome Comparison of 7565 Cases.
In: Cancers, Bd. 11, Nr. 2, 160
Simonetto, Cristoforo; Eidemüller, Markus; Gaasch, Aurelie; Pazos, Montserrat; Schönecker, Stephan; Reitz, Daniel; Kääb, Stefan; Braun, Michael; Harbeck, Nadia; Niyazi, Maximilian; Belka, Claus und Corradini, Stefanie
(2019):
Does deep inspiration breath-hold prolong life? Individual risk estimates of ischaemic heart disease after breast cancer radiotherapy.
In: Radiotherapy and Oncology, Bd. 131: S. 202-207
Müller, Katharina; Sixou, Sophie; Kuhn, Christina; Jalaguier, Stephan; Mayr, Doris; Ditsch, Nina; Weissenbacher, Tobias; Harbeck, Nadia; Mahner, Sven; Cavailles, Vincent und Jeschke, Udo
(2019):
Prognostic Relevance of RIP140 and ER Expression in Unifocal Versus Multifocal Breast Cancers: A Preliminary Report.
In: International Journal of Molecular Sciences, Bd. 20, Nr. 2, 418
Ditsch, Nina; Untch, Michael; Thill, Marc; Müller, Volkmar; Janni, Wolfgang; Albert, Ute-Susann; Bauerfeind, Ingo; Blohmer, Jens; Budach, Wilfried; Dall, Peter; Diel, Ingo; Fasching, Peter A.; Fehm, Tanja; Friedrich, Michael; Gerber, Bernd; Hanf, Volker; Harbeck, Nadia; Huober, Jens; Jackisch, Christian; Kolberg-Liedtke, Cornelia; Kreipe, Hans-Heinrich; Krug, David; Kühn, Thorsten; Kümmel, Sherko; Loibl, Sibylle; Lueftner, Diana; Lux, Michael Patrick; Maass, Nicolai; Moebus, Volker; Müller-Schimpfle, Markus; Mundhenke, Christoph; Nitz, Ulrike; Rhiem, Kerstin; Rody, Achim; Schmidt, Marcus; Schneeweiss, Andreas; Schuetz, Florian; Sinn, Hans-Peter; Solbach, Christine; Solomayer, Erich-Franz; Stickeler, Elmar; Thomssen, Christoph; Wenz, Frederik; Witzel, Isabell und Woeckel, Achim
(2019):
AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2019.
In: Breast Care, Bd. 14, Nr. 4: S. 224-245
Thill, Marc; Jackisch, Christian; Janni, Wolfgang; Müller, Volkmar; Albert, Ute-Susann; Bauerfeind, Ingo; Blohmer, Jens; Budach, Wilfried; Dall, Peter; Diel, Ingo; Fasching, Peter A.; Fehm, Tanja; Friedrich, Michael; Gerber, Bernd; Hanf, Volker; Harbeck, Nadia; Huober, Jens; Kolberg-Liedtke, Cornelia; Kreipe, Hans-Heinrich; Krug, David; Kühn, Thorsten; Kümmel, Sherko; Loibl, Sibylle; Lueftner, Diana; Lux, Michael Patrick; Maass, Nicolai; Moebus, Volker; Müller-Schimpfle, Markus; Mundhenke, Christoph; Nitz, Ulrike; Rhiem, Kerstin; Rody, Achim; Schmidt, Marcus; Schneeweiss, Andreas; Schuetz, Florian; Sinn, Hans-Peter; Solbach, Christine; Solomayer, Erich-Franz; Stickeler, Elmar; Thomssen, Christoph; Untch, Michael; Wenz, Frederik; Witzel, Isabell; Woeckel, Achim und Ditsch, Nina
(2019):
AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2019.
In: Breast Care, Bd. 14, Nr. 4: S. 247-255
Tremmel, Eileen; Hofmann, Simone; Kuhn, Christina; Heidegger, Helene; Heublein, Sabine; Hermelink, Kerstin; Wuerstlein, Rachel; Harbeck, Nadia; Mayr, Doris; Mahner, Sven; Ditsch, Nina; Jeschke, Udo und Vattai, Aurelia
(2019):
Thyronamine regulation of TAAR1 expression in breast cancer cells and investigation of its influence on viability and migration.
In: Breast Cancer-Targets and Therapy, Bd. 11: S. 87-97
Nabieva, Naiba; Haeberle, Lothar; Brucker, Sara Y.; Janni, Wolfgang; Volz, Bernhard; Loehberg, Christian R.; Hartkopf, Andreas D.; Walter, Christina Barbara; Baake, Gerold; Fridman, Alexander; Malter, Wolfram; Wuerstlein, Rachel; Harbeck, Nadia; Hoffmann, Oliver; Kümmel, Sherko; Martin, Bernhard; Thomssen, Christoph; Graf, Heiko; Wolf, Christopher; Lux, Michael P.; Bayer, Christian M.; Rauh, Claudia; Hack, Carotin C.; Almstedt, Katrin; Gass, Paul; Heindl, Felix; Brodkorb, Tobias; Lindner, Christoph; Kolberg, Hans-Christian; Krabisch, Petra; Weigel, Michael; Steinfeld-Birg, Dieter; Kohls, Andreas; Brucker, Cosima; Schulz, Volker; Fischer, Gunnar; Pelzer, Volker; Rack, Brigitte; Beckmann, Matthias W.; Fehm, Tanja; Rody, Achim; Maass, Nicolai; Hein, Alexander und Fasching, Peter A.
(2019):
Preexisting musculoskeletal burden and its development under letrozole treatment in early breast cancer patients.
In: International Journal of Cancer, Bd. 145, Nr. 8: S. 2114-2121
Garcia-Etienne, Carlos A.; Mansel, Robert E.; Tomatis, Mariano; Hei, Jörg; Biganzoli, Laura; Ferrari, Alberta; Marotti, Lorenza; Sgarella, Adele; Ponti, Antonio; Danaei, Mahmoud; Stickeler, Elmar; Sarlos, Dimitri; Prove, Annemie; Pagani, Olivia; Berclaz, Gilles; Taffurelli, Mario; Cretella, Elisabetta; Verhoeven, Didier; Denk, Andreas; Carly, Birgit; Ballardini, Bettina; Riet, Yvonne van; Kimmig, Rainer; Reinisch, Mattea; Angiolini, Catia; Moebus, Volker; Emons, Gunter; Friedrichs, Kay; Schneeweiss, Andreas; Tinterri, Corrado; Egle, Daniel; Staelens, Gracienne; Kiechle, Marion; Harbeck, Nadia; Corsi, Fabio; Menghini, Lorenzo; Lombardi, Augusto; Fortunato, Lucio; Bortul, Marina; Huober, Jens; Badbanchi, Farzaneh und Tausch, Christoph
(2019):
Trends in axillary lymph node dissection for early-stage breast cancer in Europe: Impact of evidence on practice.
In: Breast, Bd. 45: S. 89-96
Harbeck, Nadia; Wang, Jessie; Otto, Gordon Philipp; Gattu, Sreekanth und Krendyukov, Andriy
(2019):
Safety analysis of proposed pegfilgrastim biosimilar in Phase I and Phase III studies.
In: Future Oncology, Bd. 15, Nr. 12: S. 1313-1322
Wunderle, Marius; Pretscher, Jutta; Brucker, Sara Y.; Volz, Bernhard; Hartmann, Arndt; Fiessler, Cornelia; Hein, Alexander; Haeberle, Lothar; Jud, Sebastian M.; Lux, Michael P.; Janni, Wolfgang; Loehberg, Christian R.; Hartkopf, Andreas D.; Walter, Christina Barbara; Baake, Gerold; Fridman, Alexander; Malter, Wolfram; Wuerstlein, Rachel; Harbeck, Nadia; Hoffmann, Oliver; Kümmel, Sherko; Martin, Bernhard; Thomssen, Christoph; Graf, Heiko; Wolf, Christopher; Bayer, Christian M.; Hack, Carolin C.; Almstedt, Katrin; Gass, Paul; Heindl, Felix; Brodkorb, Tobias F.; Nabieva, Naiba; Lindner, Christoph; Kolberg, Hans-Christian; Krabisch, Petra; Weigel, Michael; Steinfeld-Birg, Dieter; Kohls, Andreas; Brucker, Cosima; Schulz, Volker; Fischer, Gunnar; Pelzer, Volker; Wallwiener, Diethelm; Rack, Brigitte; Fehm, Tanja; Rody, Achim; Maass, Nicolai; Beckmann, Matthias W.; Fasching, Peter A. und Rauh, Claudia
(2019):
Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer.
In: Breast Cancer Research and Treatment, Bd. 174, Nr. 2: S. 453-461
Christgen, Matthias; Bartels, Stephan; Radner, Martin; Raap, Mieke; Rieger, Luisa; Christgen, Henriette; Gluz, Oleg; Nitz, Ulrike; Harbeck, Nadia; Lehmann, Ulrich und Kreipe, Hans
(2019):
ERBB2 mutation frequency in lobular breast cancer with pleomorphic histology or high-risk characteristics by molecular expression profiling.
In: Genes Chromosomes & Cancer, Bd. 58, Nr. 3: S. 175-185
Liu, Minetta C.; Janni, Wolfgang; Georgoulias, Vassilis; Yardley, Denise A.; Harbeck, Nadia; Wei, Xin; McGovern, Desmond und Beck, Robert
(2019):
First-Line Doublet Chemotherapy for Metastatic Triple-Negative Breast Cancer: Circulating Tumor Cell Analysis of the tnAcity Trial.
In: Cancer Management and Research, Bd. 11: S. 10427-10433
Balic, Marija; Thomssen, Christoph; Wuerstlein, Rachel; Gnant, Michael und Harbeck, Nadia
(2019):
St. Gallen/Vienna 2019: A Brief Summary of the Consensus Discussion on the Optimal Primary Breast Cancer Treatment.
In: Breast Care, Bd. 14, Nr. 2: S. 103-110
Pichler, Theresia; Dinkel, Andreas; Marten-Mittag, Birgitt; Hermelink, Kerstin; Telzerow, Eva; Ackermann, Ulrike; Belka, Claus; Combs, Stephanie E.; Gratzke, Christian; Gschwend, Jürgen; Harbeck, Nadia; Heinemann, Volker; Herkommer, Kathleen; Kiechle, Marion; Mahner, Sven; Pigorsch, Steffi; Rauch, Josefine; Stief, Christian; Beckmann, Jürgen; Heussner, Pia und Herschbach, Peter
(2019):
Factors associated with the decline of psychological support in hospitalized patients with cancer.
In: Psycho-Oncology, Bd. 28, Nr. 10: S. 2049-2059
Wallwiener, Markus; Nabieva, Naiba; Feisst, Manuel; Fehm, Tanja; de Waal, Johann; Rezai, Mahdi; Baier, Bernd; Baake, Gerold; Kolberg, Hans-Christian; Guggenberger, Martin; Warm, Mathias; Harbeck, Nadia; Wuerstlein, Rachel; Deuker, Jörg-Uwe; Dall, Peter; Richter, Barbara; Wachsmann, Grischa; Brucker, Cosima; Siebers, Jan Willem; Popovic, Milos; Kuhn, Thomas; Wolf, Christopher; Vollert, Hans-Walter; Breitbach, Georg-Peter; Janni, Wolfgang; Landthaler, Robert; Kohls, Andreas; Rezek, Daniela; Noesselt, Thomas; Fischer, Gunnar; Henschen, Stephan; Praetz, Thomas; Heyl, Volker; Kühn, Thorsten; Krauss, Thomas; Thomssen, Christoph; Hohn, Andre; Tesch, Hans; Mundhenke, Christoph; Hein, Alexander; Rauh, Claudia; Bayer, Christian M.; Schmidt, Katja; Belleville, Erik; Brucker, Sara Y.; Hadji, Peyman; Beckmann, Matthias W.; Wallwiener, Diethelm; Kümmel, Sherko; Hartkopf, Andreas und Fasching, Peter A.
(2019):
Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study.
In: BMC Cancer, Bd. 19, 611
Hurvitz, Sara A.; Martin, Miguel; Jung, Kyung Hae; Huang, Chiun-Sheng; Harbeck, Nadia; Valero, Vicente; Stroyakovskiy, Daniil; Wildiers, Hans; Campone, Mario; Boileau, Jean-Francois; Fasching, Peter A.; Afenjar, Karen; Spera, Gonzalo; Lopez-Valverde, Vanesa; Song, Chunyan; Trask, Peter; Boulet, Thomas; Sparano, Joseph A.; Symmans, W. Fraser; Thompson, Alastair M. und Slamon, Dennis
(2019):
Neoadjuvant Trastuzumab Emtansine and Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Three-Year Outcomes From the Phase III KRISTINE Study.
In: Journal of Clinical Oncology, Bd. 37, Nr. 25
Di Cosimo, Serena; Triulzi, Tiziana; Pizzamiglio, Sara; De Cecco, Loris; de Azambuja, Evandro; Fumagalli, Debora; Putzai, Lajos; Harbeck, Nadia; Izquierdo, Miguel; de la Pena, Lorena; Daidone, Maria Grazia; Huober, Jens; Gori, Stefania; Cinieri, Saverio; Torri, Valter; Baselga, Jose; Piccart, Martine; de Braud, Filippo G.; Apolone, Giovanni; Verderio, Paolo und Tagliabue, Elda
(2019):
The 41-gene classifier TRAR predicts response of HER2 positive breast cancer patients in the NeoALTTO study.
In: European Journal of Cancer, Bd. 118: S. 1-9
Untch, Michael; Thomssen, Christoph; Bauerfeind, Ingo; Braun, Michael; Brucker, Sara Y.; Felberbaum, Ricardo; Hagemann, Friederike; Haidinger, Renate; Hoenig, Arnd; Huober, Jens; Jackisch, Christian; Kolberg, Hans-Christian; Kolberg-Liedtke, Cornelia; Kühn, Thorsten; Lueftner, Diana; Maass, Nicolai; Reimer, Toralf; Schneeweiss, Andreas; Schumacher-Wulf, Eva; Schuetz, Florian; Thill, Marc; Wuerstlein, Rachel; Fasching, Peter A. und Harbeck, Nadia
(2019):
Primary Therapy of Early Breast Cancer: Evidence, Controversies, Consensus.
In: Geburtshilfe und Frauenheilkunde, Bd. 79, Nr. 6: S. 591-604
Nitz, Ulrike; Gluz, Oleg; Clemens, Michael; Malter, Wolfram; Reimer, Toralf; Nuding, Benno; Aktas, Bahriye; Stefek, Andrea; Pollmanns, Anke; Lorenz-Salehi, Fatemeh; Uleer, Christoph; Krabisch, Petra; Kümmel, Sherko; Liedtke, Cornelia; Shak, Steven; Wuerstlein, Rachel; Christgen, Matthias; Kates, Ronald E.; Kreipe, Hans H.; Harbeck, Nadia; Ackermann, S.; Aktas, B.; Augustin, D.; Baake, G.; Baumann, K.; Berger, R.; Bettscheider, J.; Bischoff, J.; Clemens, M.; Deryal, M.; Dubbers, H.; Duchting, D.; Dunnebacke, J.; Fett, W.; Fietz, T.; Fischer, H.; Forner, M.; Forstbauer, H.; Freese, K.; Geberth, M.; Glados, M.; Gnauert, K.; Goette, O.; Gohring, U.; Goppinger, A.; Grafe, A.; Hackenberg, R.; Hackmann, J.; Hellriegel, M.; Heyl, V.; Hoestermann, C.; Hoffmann, G.; Hofmann, M.; Hucke, J.; Jackisch, C.; Jungberg, P.; Just, M.; Kahl, C.; Klare, P.; Kogel, M.; Kohls, A.; Amrawy, B. Konigs-El; Konnecke, P.; Krabisch, P.; Kraudelt, S.; Kremers, S.; Kummel, S.; Kurbacher, C.; Kusche, J.; Liedtke, B.; Liedtke, C.; Link, H.; Lorenz, R.; Salehi, F. Lorenz; Lubbe, K.; Malter, W.; Melekian, B.; Mobus, V.; Montenarh, M.; Müller, V.; Mundhenke, C.; Niederle, N.; Nitz, U.; Noesselt, T.; Oberhoff, C.; Paas, L.; Paepke, S.; Pollmanns, A.; Reichert, D.; Reimer, T.; Romann, D.; Ruhland, T.; Runde, V.; Salem, M.; Schlosser, A.; Schneider, A.; Schrader, I.; Schulz, H.; Schumacher, C.; Schwickerath, J.; Soling, U.; Stauder, H.; Stefek, A.; Steinmetz, T.; Stickeler, E.; Terhaag, J.; Thomssen, C.; Tome, O.; Uleer, C.; Warm, M.; Wachsmann, G.; Wacker, J.; Wiebringhaus, H.; Wiest, W.; Wolfgarten, M.; Nitz, U.; Christgen, H.; Kreipe, H.; Buehne, C.; Gluz, O.; Hansen, K.; Hofmann, D.; Kates, R.; Mangold, M.; Mathissen, M.; Raeth, P.; Renner, I.; Reiser, I.; Schumacher, J.; Staedele, M. und Walter-Kirst, R.
(2019):
West German Study PlanB Trial: Adjuvant Four Cycles of Epirubicin and Cyclophosphamide Plus Docetaxel Versus Six Cycles of Docetaxel and Cyclophosphamide in HER2-Negative Early Breast Cancer.
In: Journal of Clinical Oncology, Bd. 37, Nr. 10
Märkl, Bruno; Kazik, Martin; Harbeck, Nadia; Jakubowicz, Elzbieta; Hoffmann, Reinhard; Jung, Thomas; Steinfeld, Dieter; Schenkirsch, Gerhard; Schlimok, Günter und Oruzio, Daniel
(2019):
Impact of uPA/PAI-1 and disseminated cytokeratin-positive cells in breast cancer.
In: BMC Cancer
19:692
[PDF, 1MB]
Harbeck, Nadia
(2019):
Emerging strategies in neoadjuvant treatment of patients with HER2-positive early breast cancer.
In: Breast, Bd. 48:
S97-S102
Braun, Leah T.; Pfahler, Vanessa; Stumpf, Ulla; Escudero, Montserrat Pazos; Harbeck, Nadia und Schmidmaier, Ralf
(2019):
Knochengesundheit bei Tumorpatienten.
In: Onkologe, Bd. 25, Nr. 12: S. 1121-1134
Harbeck, Nadia; Penault-Llorca, Frederique; Cortes, Javier; Gnant, Michael; Houssami, Nehmat; Poortmans, Philip; Ruddy, Kathryn; Tsang, Janice und Cardoso, Fatima
(2019):
Breast cancer.
In: Nature Reviews Disease Primers, Bd. 5, 66
Turner, Nicholas C.; Liu, Yuan; Zhu, Zhou; Loi, Sherene; Colleoni, Marco; Loibl, Sibylle; DeMichele, Angela; Harbeck, Nadia; Andre, Fabrice; Bayar, Mohamed Amine; Michiels, Stefan; Zhang, Zhe; Giorgetti, Carla; Arnedos, Monica; Bartlett, Cynthia Huang und Cristofanilli, Massimo
(2019):
Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor-Positive Metastatic Breast Cancer.
In: Journal of Clinical Oncology, Bd. 37, Nr. 14
Eggersmann, Tanja K.; Degenhardt, Tom; Gluz, Oleg; Wuerstlein, Rachel und Harbeck, Nadia
(2019):
CDK4/6 Inhibitors Expand the Therapeutic Options in Breast Cancer: Palbociclib, Ribociclib and Abemaciclib.
In: Biodrugs, Bd. 33, Nr. 2: S. 125-135
Rogowski, Paul; Schönecker, Stephan; Pazos, Montserrat; Reitz, Daniel; Braun, Michael; Poelcher, Martin; Hanusch, Claus; Wuerstlein, Rachel; Harbeck, Nadia; Mahner, Sven; Belka, Claus und Corradini, Stefanie
(2019):
Pattern of care of adjuvant radiotherapy in male breast cancer patients in clinical practice: an observational study.
In: Strahlentherapie und Onkologie, Bd. 195, Nr. 4: S. 289-296
Burgman, Maximiliane; Hermelink, Kerstin; Farr, Alex; Meegen, Friederike van; Heiduschk, Annika; Engel, Jutta; Kolben, Thomas; Degenhardt, Tom; Ditsch, Nina; Mahner, Sven; Harbeck, Nadia und Würstlein, Rachel
(2018):
Evaluation of Reproductive Concerns and Biographical Impact of Breast Cancer in Young Patients.
In: Breast Care, Bd. 13, Nr. 2: S. 126-130
Corradini, Stefanie; Pazos, Montserrat; Schönecker, Stephan; Reitz, Daniel; Niyazi, Maximilian; Ganswindt, Ute; Schrodi, Simone; Braun, Michael; Pölcher, Martin; Mahner, Sven; Harbeck, Nadia; Engel, Jutta und Belka, Claus
(2018):
Role of postoperative radiotherapy in reducing ipsilateral recurrence in DCIS: An observational study of 1048 cases.
In: Radiation Oncology
13: S. 1-9
[PDF, 670kB]
Sixou, Sophie; Müller, Katharina; Jalaguier, Stéphan; Kuhn, Christina; Harbeck, Nadia; Mayr, Doris; Engel, Jutta; Jeschke, Udo; Ditsch, Nina und Cavaillès, Vincent
(2018):
Importance of RIP140 and LCoR Sub-Cellular Localization for Their Association With Breast Cancer Aggressiveness and Patient Survival.
In: Translational Oncology, Bd. 11, Nr. 5: S. 1090-1096
[PDF, 1MB]
Wöckel, Achim; Buck, Andreas; Stangl, Stephanie; Engel, Jutta; Hölzel, Dieter und Harbeck, Nadia
(2018):
Interdisciplinary Screening, Diagnosis, Therapy and Follow-up of Breast Cancery, Recurrent and Advanced Breast Cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 2 with Recommendations for the Therapy of Primar.
In: Geburtshilfe und Frauenheilkunde, Bd. 78, Nr. 11: S. 1056-1088
Widschwendter, Martin; Jones, Allison; Evans, Iona; Reiser, Daniel; Dillner, Joakim; Sundstrom, Karin; Steyerberg, Ewout W.; Vergouwe, Yvonne; Wegwarth, Odette; Rebitschek, Felix G.; Siebert, Uwe; Sroczynski, Gaby; Beaufort, Inez D. de; Bolt, Ineke; Cibula, David; Zikan, Michal; Bjorge, Line; Colombo, Nicoletta; Harbeck, Nadia; Dudbridge, Frank; Tasse, Anne-Marie; Knoppers, Bartha M.; Joly, Yann; Teschendorff, Andrew E. und Pashayan, Nora
(2018):
Epigenome-based cancer risk prediction: rationale, opportunities and challenges.
In: Nature Reviews Clinical Oncology, Bd. 15, Nr. 5: S. 292-309
Schultz, Silke; Bartsch, Harald; Sotlar, Karl; Petat-Dutter, Karina; Bonin, Michael; Kahlert, Steffen; Harbeck, Nadia; Vogel, Ulrich; Seeger, Harald; Fehm, Tanja und Neubauer, Hans J.
(2018):
Progression-specific genes identified in microdissected formalin-fixed and paraffin-embedded tissue containing matched ductal carcinoma in situ and invasive ductal breast cancers.
In: BMC Medical Genomics
11:80
[PDF, 1MB]
Powles, Ryan L.; Redmond, David; Sotiriou, Christos; Loi, Sherene; Fumagalli, Debora; Nuciforo, Paolo; Harbeck, Nadia; Azambuja, Evandro de; Sarp, Severine; Di Cosimo, Serena; Huober, Jens; Baselga, Jose; Piccart-Gebhart, Martine; Elemento, Olivier; Pusztai, Lajos und Hatzis, Christos
(2018):
Association of T-Cell Receptor Repertoire Use With Response to Combined Trastuzumab-Lapatinib Treatment of HER2-Positive Breast Cancer Secondary Analysis of the NeoALTTO Randomized Clinical Trial.
In: Jama Oncology, Bd. 4, Nr. 11, e181564
Tripathy, Debu; Im, Seock-Ah; Colleoni, Marco; Franke, Fabio; Bardia, Aditya; Harbeck, Nadia; Hurvitz, Sara A.; Chow, Louis; Sohn, Joohyuk; Lee, Keun Seok; Campos-Gomez, Saul; Vazquez, Rafael Villanueva; Jung, Kyung Hae; Babu, K. Govind; Wheatley-Price, Paul; Laurentiis, Michelino de; Im, Young-Hyuck; Kümmel, Sherko; El-Saghir, Nagi; Liu, Mei-Ching; Carlson, Gary; Hughes, Gareth; Diaz-Padilla, Ivan; Germa, Caroline; Hirawat, Samit und Lu, Yen-Shen
(2018):
Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial.
In: Lancet Oncology, Bd. 19, Nr. 7: S. 904-915
Raap, Mieke; Gronewold, Malte; Christgen, Henriette; Glage, Silke; Bentires-Alj, Mohammad; Koren, Shany; Derksen, Patrick W.; Bölens, Mirjam; Jonkers, Jos; Lehmann, Ulrich; Feuerhake, Friedrich; Kühnle, Elna; Gluz, Oleg; Kates, Ronald; Nitz, Ulrike; Harbeck, Nadia; Kreipe, Hans H. und Christgen, Matthias
(2018):
Lobular carcinoma in situ and invasive lobular breast cancer are characterized by enhanced expression of transcription factor AP-2 beta.
In: Laboratory Investigation, Bd. 98, Nr. 1: S. 117-129
Untch, Michael; Würstlein, Rachel; Marschner, Norbert; Lüftner, Diana; Augustin, Doris; Briest, Susanne; Ettl, Johannes; Haidinger, Renate; Müller, Lothar; Müller, Volkmar; Ruckhäberle, Eugen; Harbeck, Nadia und Thomssen, Christoph
(2018):
4th International Consensus Conference on Advanced Breast Cancer (ABC4), Lisbon, November 4, 2017: ABC4 Consensus: Assessment by a Panel of German Experts.
In: Geburtshilfe und Frauenheilkunde, Bd. 78, Nr. 5: S. 469-480
Harbeck, Nadia; Lüftner, Diana; Marschner, Norbert; Untch, Michael; Augustin, Doris; Briest, Susanne; Ettl, Johannes; Haidinger, Renate; Müller, Lothar; Müller, Volkmar; Ruckhäberle, Eugen; Würstlein, Rachel und Thomssen, Christoph
(2018):
ABC4 Consensus: Assessment by a German Group of Experts.
In: Breast Care, Bd. 13, Nr. 1: S. 48-58
Harbeck, Nadia
(2018):
Advances in targeting HER2-positive breast cancer.
In: Current Opinion in Obstetrics & Gynecology, Bd. 30, Nr. 1: S. 55-59
Semmlinger, Anna; Schönfeldt, Viktoria von; Wolf, Verena; Meuter, Alexandra; Kolben, Theresa Maria; Kolben, Thomas; Zeder-Goess, Christine; Weis, Florian; Gallwas, Julia; Würstlein, Rachel; Hermelink, Kerstin; Schmoeckel, Elisa; Harbeck, Nadia; Mayr, Doris; Mahner, Sven; Jeschke, Udo und Ditsch, Nina
(2018):
EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer.
In: BMC Cancer
18:431
[PDF, 927kB]
Kolben, Thomas; Jeschke, Udo; Reimer, Toralf; Karsten, Nora; Schmoeckel, Elisa; Semmlinger, Anna; Mahner, Sven; Harbeck, Nadia und Kolben, Theresa M.
(2018):
Induction of apoptosis in breast cancer cells in vitro by Fas ligand reverse signaling.
In: Journal of Cancer Research and Clinical Oncology, Bd. 144, Nr. 2: S. 249-256
Rugo, Hope S.; Turner, Nicholas C.; Finn, Richard S.; Joy, Anil A.; Verma, Sunil; Harbeck, Nadia; Masuda, Norikazu; Im, Seock-Ah; Huang, Xin; Kim, Sindy; Sun, Wan; Iyer, Shrividya; Schnell, Patrick; Bartlett, Cynthia Huang und Johnston, Stephen
(2018):
Palbociclib plus endocrine therapy in older women with HR+/HER2-advanced breast cancer: a pooled analysis of randomised PALOMA clinical studies.
In: European Journal of Cancer, Bd. 101: S. 123-133
Kahlert, Steffen; Kolben, Theresa M.; Schmoeckel, Elisa; Czogalla, Bastian; Hester, Anna; Degenhardt, Tom; Kempf, Cordula; Mahner, Sven; Harbeck, Nadia und Kolben, Thomas
(2018):
Prognostic impact of residual disease in simultaneous additional excision specimens after one-step breast conserving therapy with negative final margin status in primary breast cancer.
In: Ejso, Bd. 44, Nr. 9: S. 1318-1323
Pazos, Montserrat; Schönecker, Stephan; Reitz, Daniel; Rogowski, Paul; Niyazi, Maximilian; Alongi, Filippo; Matuschek, Christiane; Braun, Michael; Harbeck, Nadia; Belka, Claus und Corradini, Stefanie
(2018):
Recent Developments in Radiation Oncology: An Overview of Individualised Treatment Strategies in Breast Cancer.
In: Breast Care, Bd. 13, Nr. 4: S. 285-291
Harbeck, Nadia; Gascon, Pere; Krendyukov, Andriy; Hoebel, Nadja; Gattu, Sreekanth und Blackwell, Kimberly
(2018):
Safety Profile of Biosimilar Filgrastim (Zarzio/Zarxio): A Combined Analysis of Phase III Studies.
In: Oncologist, Bd. 23, Nr. 4: S. 403-409
Degenhardt, Tom; Würstlein, Rachel; Eggersmann, Tanja und Harbeck, Nadia
(2018):
The safety of palbociclib for the treatment of advanced breast cancer.
In: Expert Opinion on Drug Safety, Bd. 17, Nr. 3: S. 325-330
Kolben, Thomas; Haberland, Birgit; Degenhardt, Tom; Burgmann, Maximiliane; König, Alexander; Kolben, Theresa Maria; Ulbach, Kristina; Mahner, Sven; Bausewein, Claudia; Harbeck, Nadia und Würstlein, Rachel
(2018):
Evaluation of an interdisciplinary palliative care inhouse training for professionals in gynecological oncology.
In: Archives of Gynecology and Obstetrics, Bd. 297, Nr. 3: S. 767-773
Ponde, Noam; Bradbury, Ian; Lambertini, Matteo; Ewer, Michael; Campbell, Christine; Ameels, Helene; Zardavas, Dimitrios; Di Cosimo, Serena; Baselga, Jose; Huober, Jens; Izquierdo, Miguel; Fumagalli, Debora; Bozovic-Spasojevic, Ivana; Maetens, Marion; Harbeck, Nadia; Pusztai, Lajos; Berghorn, Michael; Im, Young-Hyuck; Ruiz Borrego, Manuel; Chen, Dar-Ren; Rodeheffer, Richard; Piccart, Martine; Suter, Thomas und Azambuja, Evandro de
(2018):
Cardiac biomarkers for early detection and prediction of trastuzumab and/or lapatinib-induced cardiotoxicity in patients with HER2-positive early-stage breast cancer: a NeoALTTO sub-study (BIG 1-06).
In: Breast Cancer Research and Treatment, Bd. 168, Nr. 3: S. 631-638
Absmaier, Magdalena; Napieralski, Rudolf; Schuster, Tibor; Aubele, Michaela; Walch, Axel; Magdolen, Viktor; Dorn, Julia; Gross, Eva; Harbeck, Nadia; Noske, Aurelia; Kiechle, Marion und Schmitt, Manfred
(2018):
PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients.
In: International Journal of Oncology, Bd. 52, Nr. 3: S. 755-767
Filipits, Martin; Dafni, Urania; Gnant, Michael; Polydoropoulou, Varvara; Hills, Margaret; Kiermaier, Astrid; Azambuja, Evandro de; Larsimont, Denis; Rojo, Federico; Viale, Giuseppe; Toi, Masakazu; Harbeck, Nadia; Prichard, Kathleen I.; Gelber, Richard D.; Dinh, Phuong; Zardavas, Dimitrios; Leyland-Jones, Brian; Piccart-Gebhart, Martine J. und Dowsett, Mitch
(2018):
Association of p27 and Cyclin D1 Expression and Benefit from Adjuvant Trastuzumab Treatment in HER2-Positive Early Breast Cancer: A TransHERA Study.
In: Clinical Cancer Research, Bd. 24, Nr. 13: S. 3079-3086
Gluz, Oleg; Nitz, Ulrike; Liedtke, Cornelia; Christgen, Matthias; Grischke, Eva-Maria; Forstbauer, Helmut; Braun, Michael; Warm, Mathias; Hackmann, John; Uleer, Christoph; Aktas, Bahriye; Schumacher, Claudia; Bangemann, Nikola; Lindner, Christoph; Kuemmel, Sherko; Clemens, Michael; Potenberg, Jochem; Staib, Peter; Kohls, Andreas; Schumann, Raquel von und Harbeck, Nadia
(2018):
Comparison of Neoadjuvant Nab-Paclitaxe plus Carboplatin vs Nab-Paclitaxe plus Gemcitabine in Triple-Negative Breast Cancer: Randomized WSG-ADAPT-TN Trial Results.
In: Jnci-Journal of the National Cancer Institute, Bd. 110, Nr. 6, djx258: S. 628-637
Hurvitz, Sara A.; Martin, Miguel; Symmans, W. Fraser; Jung, Kyung Hae; Huang, Chiun-Sheng; Thompson, Alastair M.; Harbeck, Nadia; Valero, Vicente; Stroyakovskiy, Daniil; Wildiers, Hans; Campone, Mario; Boileau, Jean-Francois; Beckmann, Matthias W.; Afenjar, Karen; Fresco, Rodrigo; Helms, Hans-Joachim; Xu, Jin; Lin, Yvonne G.; Sparano, Joseph und Slamon, Dennis
(2018):
Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial.
In: Lancet Oncology, Bd. 19, Nr. 1: S. 115-126
Mutschler, Nikola S.; Scholz, Christoph; Friedl, Thomas W. P.; Zwingers, Thomas; Fasching, Peter A.; Beckmann, Matthias W.; Fehm, Tanja; Mohrmann, Svjetlana; Salmen, Jessica; Ziegler, Carola; Jaeger, Bernadette; Widschwendter, Peter; Gregorio, Nikolaus de; Schochter, Fabienne; Mahner, Sven; Harbeck, Nadia; Weissenbacher, Tobias; Jückstock, Julia; Janni, Wolfgang und Rack, Brigitte
(2018):
Prognostic Impact of Weight Change During Adjuvant Chemotherapy in Patients With High-Risk Early Breast Cancer: Results From the ADEBAR Study.
In: Clinical Breast Cancer, Bd. 18, Nr. 2: S. 175-183
Hepp, Philip; Fasching, Peter A.; Beckmann, Matthias W.; Fehm, Tanja; Salmen, Jessica; Hagenbeck, Carsten; Jaeger, Bernadette; Widschwendter, Peter; Gregorio, Nikolaus de; Schochter, Fabienne; Mahner, Sven; Harbeck, Nadia; Weissenbacher, Tobias; Kurt, Ayse-Guel; Friedl, Thomas W. P.; Janni, Wolfgang und Rack, Brigitte
(2018):
Use of Granulocyte-colony Stimulating Factor During Chemotherapy and Its Association With CA27.29 and Circulating Tumor Cells-Results From the SUCCESS A Trial.
In: Clinical Breast Cancer, Bd. 18, Nr. 5, E1103-E1110
Hermelink, Kerstin; Bühner, Markus; Munzel, Karin; Mahner, Sven und Harbeck, Nadia
(1. Oktober 2017):
RE: Post-traumatic Stress as the Primary Cause for Cognitive Declin—Not the Whole Story, and Perhaps No Story at All.
In: Journal of the National Cancer Institute, Bd. 109, Nr. 10
Hermelink, Kerstin; Bühner, Markus; Sckopke, Philipp; Neufeld, Franziska; Kaste, Judith; Voigt, Varinka; Münzel, Karin; Wuerstlein, Rachel; Ditsch, Nina; Hellerhoff, Karin; Rjosk-Dendorfer, Dorothea; Braun, Michael; Koch, Franz Edler von; Härtl, Kristin; Hasmüller, Stephan; Bauerfeind, Ingo; Debus, Gerlinde; Herschbach, Peter; Mahner, Sven und Harbeck, Nadia
(1. Oktober 2017):
Chemotherapy and Post-traumatic Stress in the Causation of Cognitive Dysfunction in Breast Cancer Patients.
In: Journal of the National Cancer Institute, Bd. 109, Nr. 10
Hölzel, Dieter; Eckel, Renate; Bauerfeind, Ingo; Baier, Bernd; Beck, Thomas; Braun, Michael; Ettl, Johannes; Hamann, Ulrich; Harbeck, Nadia; Kiechle, Marion; Mahner, Sven; Schindlbeck, Christian; Waal, Johann de und Engel, Jutta
(2017):
Survival of de novo stage IV breast cancer patients over three decades.
In: Journal of cancer research and clinical oncology, Bd. 143, Nr. 3: S. 509-519
Hölzel, Dieter; Eckel, Renate; Bauerfeind, Ingo; Baier, Bernd; Beck, Thomas; Braun, Michael; Ettl, Johannes; Hamann, Ulrich; Kiechle, Marion; Mahner, Sven; Schindlbeck, Christian; Waal, Johann de; Harbeck, Nadia und Engel, Jutta
(2017):
Improved systemic treatment for early breast cancer improves cure rates, modifies metastatic pattern and shortens post-metastatic survival. 35-year results from the Munich Cancer Registry.
In: Journal of cancer research and clinical oncology
Corradini, Stefanie; Bauerfeind, Ingo; Belka, Claus; Brauer, Michael; Combs, Stephanie E.; Eckel, Renate; Harbeck, Nadia; Hölzel, Dieter; Kiechle, Marion; Niyazi, Maximilian und Engel, Jutta
(2017):
Trends in use and outcome of postoperative radiotherapy following mastectomy: a population-based study.
In: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, Bd. 122, Nr. 1: S. 2-10
Würstlein, Rachel; Hesse, Andreas; König, Alexander; Schulte-Vorwick, Felicitas; Schrodi, Simone; Ditsch, Nina; Mahner, Sven und Harbeck, Nadia
(2017):
Tastbefund an der Brust: Auch bei Männern immer abklären!
In: MMW Fortschritte der Medizin, Bd. 159, Nr. 21-22: S. 67-72
Voigt, Varinka; Neufeld, Franziska; Kaste, Judith; Bühner, Markus; Sckopke, Philipp; Würstlein, Rachel; Hellerhoff, Karin; Sztrokay-Gaul, Aniko; Braun, Michäl; Edler von Koch, Franz; Silva-Zürcher, Eliane; Hasmüller, Stephan; Bauerfeind, Ingo; Debus, Gerlinde; Herschbach, Peter; Mahner, Sven; Harbeck, Nadia und Hermelink, Kerstin
(2017):
Clinically assessed posttraumatic stress in patients with breast cancer during the first year after diagnosis in the prospective, longitudinal, controlled COGNICARES study.
In: Psycho-Oncology, Bd. 26, Nr. 1: S. 74-80
Schneeweiss, Andreas; Huober, Jens; Jackisch, Christian; Liedtke, Cornelia; Harbeck, Nadia und Untch, Michael
(2017):
15. Internationale St.-Gallen-Konsensus-Konferenz: Behandlung des frühen Mammakarzinoms. Praxisrelevante Statements deutscher Experten.
In: Onkologe, Bd. 23, Nr. 8: S. 666-677
Vattai, Aurelia; Akyol, Elif; Kuhn, Christina; Hofmann, Simone; Heidegger, Helene; Koch, Franz von; Hermelink, Kerstin; Würstlein, Rachel; Harbeck, Nadia; Mayr, Doris; Spitzweg, Christine; Toth, Bettina; Mahner, Sven; Jeschke, Udo und Ditsch, Nina
(2017):
Increased trace amine-associated receptor 1 (TAAR1) expression is associated with a positive survival rate in patients with breast cancer.
In: Journal of Cancer Research and Clinical Oncology, Bd. 143, Nr. 9: S. 1637-1647
Pazos, Montserrat; Corradini, Stefanie; Dian, Darius; Bodungen, Vera von; Ditsch, Nina; Würstlein, Rachel; Schönecker, Stephan; Harbeck, Nadia; Scheithauer, Heike und Belka, Claus
(2017):
Neoadjuvant radiotherapy followed by mastectomy and immediate breast reconstruction.
In: Strahlentherapie und Onkologie, Bd. 193, Nr. 4: S. 324-331
Würstlein, Rachel und Harbeck, Nadia
(2017):
Neoadjuvant Therapy for HER2-positive Breast Cancer.
In: Reviews On Recent Clinical Trials, Bd. 12, Nr. 2: S. 81-92
Trapp, Elisabeth Katharina; Majunke, Leonie; Zill, Beate; Sommer, Harald; Andergassen, Ulrich; Koch, Julian; Harbeck, Nadia; Mahner, Sven; Friedl, Thomas Wolfram Paul; Janni, Wolfgang; Rack, Brigitte und Alunni-Fabbroni, Marianna
(2017):
LKB1 pro-oncogenic activity triggers cell survival in circulating tumor cells.
In: Molecular Oncology, Bd. 11, Nr. 11: S. 1508-1526
Harbeck, Nadia; Gluz, Oleg; Christgen, Matthias; Kates, Ronald Ernest; Braun, Michael; Küemmel, Sherko; Schumacher, Claudia; Potenberg, Jochem; Krämer, Stefan; Kleine-Tebbe, Anke; Augustin, Doris; Aktas, Bahriye; Forstbauer, Helmut; Tio, Joke; Schumann, Raquel von; Liedtke, Cornelia; Grischke, Eva-Maria; Schumacher, Johannes; Würstlein, Rachel; Kreipe, Hans Heinrich und Nitz, Ulrike Anneliese
(2017):
De-Escalation Strategies in Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Early Breast Cancer (BC): Final Analysis of the West German Study Group Adjuvant Dynamic Marker-Adjusted Personalized Therapy Trial Optimizing Risk Assessment and Therapy Response Prediction in Early BC HER2-and Hormone Receptor-Positive Phase II Randomized Trial-Efficacy, Safety, and Predictive Markers for 12 Weeks of Neoadjuvant Trastuzumab Emtansine With or Without Endocrine Therapy (ET) Versus Trastuzumab Plus ET.
In: Journal of Clinical Oncology, Bd. 35, Nr. 26: S. 3046-3056
Harbeck, Nadia und Gluz, Oleg
(2017):
Neoadjuvant therapy for triple negative and HER2-positive early breast cancer.
In: Breast, Bd. 34:
S99-S103
Harbeck, Nadia; Gascon, Pere; Jones, Clyde M.; Nixon, Allen; Krendyukov, Andriy; Nakov, Roumen; Li, Yuhan und Blackwell, Kimberly
(2017):
Proposed biosimilar pegfilgrastim (LA-EP2006) compared with reference pegfilgrastim in Asian patients with breast cancer: an exploratory comparison from two Phase III trials.
In: Future Oncology, Bd. 13, Nr. 16: S. 1385-1393
Zhang, Xi; Hofmann, Simone; Rack, Brigitte; Harbeck, Nadia; Jeschke, Udo und Sixou, Sophie
(2017):
Fluorescence Analysis of Vitamin D Receptor Status of Circulating Tumor Cells (CTCS) in Breast Cancer: From Cell Models to Metastatic Patients.
In: International Journal of Molecular Sciences, Bd. 18, Nr. 6, 1318
[PDF, 3MB]
Harbeck, Nadia und Gnant, Michael
(2017):
Breast cancer.
In: Lancet, Bd. 389, Nr. 10074: S. 1134-1150
Harbeck, Nadia; Saupe, Steffen; Jäger, Elke; Schmidt, Marcus; Kreienberg, Rolf; Müller, Lothar; Otremba, Burkhard Jörg; Waldenmaier, Dirk; Dorn, Julia; Warm, Mathias; Scholz, Michael; Untch, Michael; Wit, Maike de; Barinoff, Jana; Lück, Hans-Joachim; Harter, Philipp; Augustin, Doris; Harnett, Paul; Beckmann, Matthias W. und Al-Batran, Salah-Eddin
(2017):
A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study.
In: Breast Cancer Research and Treatment, Bd. 161, Nr. 1: S. 63-72
[PDF, 711kB]
Harbeck, Nadia; Hölzel, Dieter; Eckel, Renate; Bauerfeind, Ingo; Baier, Bernd; Beck, Thomas; Braun, Michael; Ettl, Johannes; Hamann, Ulrich; Kiechle, Marion; Mahner, Sven; Schindlbeck, Christian; Waal, Johann de und Engel, Jutta
(2017):
Adjuvant Therapies for Breast Cancer Improve Cure Rates but Appear to Shorten Post-Metastatic Survival.
In: Breast, Bd. 36:
S74-S74
Thomssen, Christoph; Decker, Thomas; Fehm, Tanja; Fuxius, Stefan; Harbeck, Nadia; Juhasz-Böss, Ingolf; Möbus, Volker; Seehase, Martina; Schollenberger, Lukas; Ruckes, Christian und Schmidt, Marcus
(2017):
A Phase II Study Of Metronomic Daily Oral Vinorelbine As First-Line Chemotherapy In Advanced/Metastatic Hormone Receptor Positive (Hr Plus )/Human Epidermal Growth Factor Receptor 2 Negative (Her2-) Breast Cancer Resistant To Endocrine Therapy: Vinometro.
In: Breast, Bd. 36:
S51-S51
Nitz, Ulrike; Gluz, Oleg; Christgen, Matthias; Kates, Ronald E.; Clemens, Michael; Malter, Wolfram; Nuding, Benno; Aktas, Bahriye; Kümmel, Sherko; Reimer, Toralf; Stefek, Andrea; Lorenz-Salehi, Fatemeh; Krabisch, Petra; Just, Marianne; Augustin, Doris; Liedtke, Cornelia; Chao, Calvin; Shak, Steven; Würstlein, Rachel; Kreipe, Hans H. und Harbeck, Nadia
(2017):
Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial.
In: Breast Cancer Research and Treatment, Bd. 165, Nr. 3: S. 573-583
Leinert, Elena; Singer, Susanne; Janni, Wolfgang; Harbeck, Nadia; Weissenbacher, Tobias; Rack, Brigitte; Augustin, Doris; Wischnik, Arthur; Kiechle, Marion; Ettl, Johannes; Fink, Visnja; Schwentner, Lukas und Eichler, Martin
(2017):
The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.
In: Clinical Breast Cancer, Bd. 17, Nr. 2: S. 100-106
Eichler, Martin; Singer, Susanne; Janni, Wolfgang; Harbeck, Nadia; Rack, Brigitte; Augustin, Doris; Wischnik, Arthur; Kiechle, Marion; Ettl, Johannes; Scholz, Christoph; Fink, Visnja und Schwentner, Lukas
(2017):
Pretreatment quality of life, performance status and their relation to treatment discontinuation and treatment changes in high-risk breast cancer patients receiving chemotherapy: results from the prospective randomized ADEBAR trial.
In: Breast Cancer, Bd. 24, Nr. 2: S. 319-325
Zhang, Xi; Harbeck, Nadia; Jeschke, Udo und Doisneau-Sixou, Sophie
(2017):
Influence of vitamin D signaling on hormone receptor status and HER2 expression in breast cancer.
In: Journal of Cancer Research and Clinical Oncology, Bd. 143, Nr. 7: S. 1107-1122
Zhang, Xi; Hofmann, Simone; Harbeck, Nadia; Jeschke, Udo und Sixou, Sophie
(2017):
Impact of Etoposide on BRCA1 Expression in Various Breast Cancer Cell Lines.
In: Drugs in R&D, Bd. 17, Nr. 4: S. 569-583
Harbeck, Nadia und Würstlein, Rachel
(2017):
Luminal Metastatic Breast Cancer: Best Sequence Of Available Therapies.
In: Breast, Bd. 36:
S22-S22
Paluch-Shimon, Shani; Pagani, Olivia; Partridge, Ann H.; Abulkhair, Omalkhair; Cardoso, Maria-Joao; Dent, Rebecca Alexandra; Gelmon, Karen; Gentilini, Oreste; Harbeck, Nadia; Margulies, Anita; Meirow, Dror; Pruneri, Giancarlo; Senkus, Elzbieta; Spanic, Tanja; Sutliff, Medha; Travado, Luzia; Peccatori, Fedro und Cardoso, Fatima
(2017):
ESO-ESMO 3rd international consensus guidelines for breast cancer in young women (BCY3).
In: Breast, Bd. 35: S. 203-217
Loibl, Sibylle; Turner, Nicholas C.; Ro, Jungsil; Cristofanilli, Massimo; Iwata, Hiroji; Im, Seock-Ah; Masuda, Norikazu; Loi, Sherene; Andre, Fabrice; Harbeck, Nadia; Verma, Sunil; Folkerd, Elizabeth; Theall, Kathy Puyana; Hoffman, Justin; Zhang, Ke; Bartlett, Cynthia Huang und Dowsett, Mitchell
(2017):
Palbociclib Combined with Fulvestrant in Premenopausal Women with Advanced Breast Cancer and Prior Progression on Endocrine Therapy: PALOMA-3 Results.
In: Oncologist, Bd. 22, Nr. 9: S. 1028-1038
Fumagalli, Debora; Venet, David; Ignatiadis, Michail; Azim, Hatem A.; Maetens, Marion; Rothé, Francoise; Salgado, Roberto; Bradbury, Ian; Pusztai, Lajos; Harbeck, Nadia; Gomez, Henry; Chang, Tsai-Wang; Coccia-Portugal, Maria Antonia; Cosimo, Serena di; Azambuja, Evandro de; Peña, Lorena de la; Nuciforo, Paolo; Brase, Jan C.; Huober, Jens; Baselga, José; Piccart, Martine; Loi, Sherene und Sotiriou, Christos
(2017):
RNA Sequencing to Predict Response to Neoadjuvant Anti-HER2 Therapy A Secondary Analysis of the NeoALTTO Randomized Clinical Trial.
In: Jama Oncology, Bd. 3, Nr. 2: S. 227-234
Ettl, Johannes und Harbeck, Nadia
(2017):
The safety and efficacy of palbociclib in the treatment of metastatic breast cancer.
In: Expert Review of Anticancer therapy, Bd. 17, Nr. 8: S. 661-668
Gnant, Michael; Harbeck, Nadia und Thomssen, Christoph
(2017):
St. Gallen/Vienna 2017: A Brief Summary of the Consensus Discussion about Escalation and De-Escalation of Primary Breast Cancer Treatment.
In: Breast Care, Bd. 12, Nr. 2: S. 102-107
Hack, Carolin C.; Fasching, Peter A.; Fehm, Tanja; Waal, Johann de; Rezai, Mahdi; Baier, Bernd; Baake, Gerold; Kolberg, Hans-Christian; Guggenberger, Martin; Warm, Mathias; Harbeck, Nadia; Wuerstlein, Rachel; Deuker, Jörg-Uwe; Dall, Peter; Richter, Barbara; Wachsmann, Grischa; Brucker, Cosima; Siebers, Jan W.; Fersis, Nikos; Kuhn, Thomas; Wolf, Christopher; Vollert, Hans-Walter; Breitbach, Georg-Peter; Janni, Wolfgang; Landthaler, Robert; Kohls, Andreas; Rezek, Daniela; Noesslet, Thomas; Fischer, Gunnar; Henschen, Stefan; Praetz, Thomas; Heyl, Volker; Kühn, Thorsten; Krauss, Thomas; Thomssen, Christoph; Hohn, Andre; Tesch, Hans; Mundhenke, Christoph; Hein, Alexander; Rauh, Claudia; Bayer, Christian M.; Jacob, Adib; Schmidt, Katja; Belleville, Erik; Hadji, Peyman; Brucker, Sara Y.; Wallwiener, Diethelm; Kümmel, Sherko; Beckmann, Matthias W. und Paepke, Daniela
(2017):
Interest in Integrative Medicine Among Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study.
In: Integrative Cancer Therapies, Bd. 16, Nr. 2: S. 165-175
[PDF, 541kB]
Blackwell, Kimberly; Donskih, Roman; Jones, C. Michael; Nixon, Allen; Vidal, Maria J.; Nakov, Roumen; Singh, Pritibha; Schaffar, Gregor; Gascon, Pere und Harbeck, Nadia
(2016):
A Comparison of Proposed Biosimilar LA-EP2006 and Reference Pegfilgrastim for the Prevention of Neutropenia in Patients With Early-Stage Breast Cancer Receiving Myelosuppressive Adjuvant or Neoadjuvant Chemotherapy: Pegfilgrastim Randomized Oncology (Supportive Care) Trial to Evaluate Comparative Treatment (PROTECT-2), a Phase III, Randomized, Double-Blind Trial.
In: Oncologist, Bd. 21, Nr. 7: S. 789-794
Gluz, Oleg; Nitz, Ulrike A.; Christgen, Matthias; Kates, Ronald E.; Shak, Steven; Clemens, Michael; Kraemer, Stefan; Aktas, Bahriye; Kuemmel, Sherko; Reimer, Toralf; Kusche, Manfred; Heyl, Volker; Lorenz-Salehi, Fatemeh; Just, Marianne; Hofmann, Daniel; Degenhardt, Tom; Liedtke, Cornelia; Svedman, Christer; Wuerstlein, Rachel; Kreipe, Hans H. und Harbeck, Nadia
(2016):
West German Study Group Phase III PlanB Trial: First Prospective Outcome Data for the 21-Gene Recurrence Score Assay and Concordance of Prognostic Markers by Central and Local Pathology Assessment.
In: Journal of Clinical Oncology, Bd. 34, Nr. 20:
2341-U66
Yardley, Denise A.; Brufsky, Adam; Coleman, Robert E.; Conte, Pierfranco F.; Cortes, Javier; Glück, Stefan; Nabholtz, Jean-Mark A.; O'Shaughnessy, Joyce; Beck, Robert M.; Ko, Amy; Renschler, Markus F.; Barton, Debora und Harbeck, Nadia
(2016):
Erratum to: Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial (vol 16, pg 575, 2015).
In: Trials
17
[PDF, 357kB]
Christgen, Matthias; Steinemann, Doris; Kühnle, Elna; Länger, Florian; Gluz, Oleg; Harbeck, Nadia und Kreipe, Hans
(2016):
Lobular breast cancer: Clinical, molecular and morphological characteristics.
In: Pathology Research and Practice, Bd. 212, Nr. 7: S. 583-597
Paluch-Shimon, Shani; Pagani, Olivia; Partridge, Ann H.; Bar-Meir, Eran; Fallowfield, Lesley; Fenlon, Deborah; Friedman, Eitan; Gelmon, Karen; Gentilini, Oreste; Geraghty, James; Harbeck, Nadia; Higgins, Stephen; Loibl, Sibylle; Moser, Elizabeth; Peccatori, Fedro; Raanani, Hila; Kaufman, Bella und Cardoso, Fatima
(2016):
Second international consensus guidelines for breast cancer in young women (BCY2).
In: Breast, Bd. 26: S. 87-99
Schwentner, Lukas; Harbeck, Nadia; Singer, Susanne; Eichler, Martin; Rack, Brigitte; Forstbauer, Helmut; Wischnik, Arthur; Scholz, Christoph; Huober, Jens; Friedl, Thomas W. P.; Weissenbacher, Tobias; Härtl, Kristin; Kiechle, Marion; Janni, Wolfgang und Fink, Visnja
(2016):
Short term quality of life with epirubicin-fluorouracil-cyclophosphamid (FEC) and sequential epirubicin/cyclophosphamid-docetaxel (EC-DOC) chemotherapy in patients with primary breast cancer - Results from the prospective multi-center randomized ADEBAR trial.
In: Breast, Bd. 27: S. 69-77
Cardoso, Fatima; Harbeck, Nadia; Mertz, Shirley und Fenech, Doris
(2016):
Evolving psychosocial, emotional, functional, and support needs of women with advanced breast cancer: Results from the Count Us, Know Us, Join Us and Here & Now surveys.
In: Breast, Bd. 28: S. 5-12
Harbeck, Nadia
(2016):
Controversies in routine clinical management and research priorities for young breast cancer patients.
In: Breast, Bd. 29:
S8-S8
Marguet, Sophie; Mazouni, Chafika; Ramaekers, Bram L. T.; Dunant, Ariane; Kates, Ronald; Jacobs, Volker R.; Joore, Manuela A.; Harbeck, Nadia und Bonastre, Julia
(2016):
European cost-effectiveness study of uPA/PAI-1 biomarkers to guide adjuvant chemotherapy decisions in breast cancer.
In: European Journal of Cancer, Bd. 63: S. 168-179
Harbeck, Nadia; Huang, Chiun-Sheng; Hurvitz, Sara; Yeh, Dah-Cherng; Shao, Zhimin; Im, Seock-Ah; Jung, Kyung Hae; Shen, Kunwei; Ro, Jungsil; Jassem, Jacek; Zhang, Qingyuan; Im, Young-Hyuck; Wojtukiewicz, Marek; Sun, Qiang; Chen, Shin-Cheh; Goeldner, Rainer-Georg; Uttenreuther-Fischer, Martina; Xu, Binghe und Piccart-Gebhart, Martine
(2016):
Afatinib plus vinorelbine versus trastuzumab plus vinorelbine in patients with HER2-overexpressing metastatic breast cancer who had progressed on one previous trastuzumab treatment (LUX-Breast 1): an open-label, randomised, phase 3 trial.
In: Lancet Oncology, Bd. 17, Nr. 3: S. 357-366
Cristofanilli, Massimo; Turner, Nicholas C.; Bondarenko, Igor; Ro, Jungsil; Im, Seock-Ah; Masuda, Norikazu; Colleoni, Marco; DeMichele, Angela; Loi, Sherene; Verma, Sunil; Iwata, Hiroji; Harbeck, Nadia; Zhang, Ke; Theall, Kathy Puyana; Jiang, Yuqiu; Bartlett, Cynthia Huang; Koehler, Maria und Slamon, Dennis
(2016):
Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial.
In: Lancet Oncology, Bd. 17, Nr. 4: S. 425-439
Harbeck, Nadia; Lipatov, Oleg; Frolova, Mona; Udovitsa, Dmitry; Topuzov, Eldar; Ganea-Motan, Doina Elena; Nakov, Roumen; Singh, Pritibha; Rudy, Anita und Blackwell, Kimberly
(2016):
Randomized, double-blind study comparing proposed biosimilar LA-EP2006 with reference pegfilgrastim in breast cancer.
In: Future Oncology, Bd. 12, Nr. 11: S. 1359-1367
Thomssen, Christoph; Augustin, Doris; Ettl, Johannes; Haidinger, Renate; Lück, Hans-Joachim; Lueftner, Diana; Marmé, Frederik; Marschner, Norbert; Müller, Lothar; Overkamp, Friedrich; Ruckhäberle, Eugen; Thill, Marc; Untch, Michael; Wuerstlein, Rachel und Harbeck, Nadia
(2016):
ABC3 Consensus: Assessment by a German Group of Experts.
In: Breast Care, Bd. 11, Nr. 1: S. 61-70
[PDF, 93kB]
Gaß, Paul; Fasching, Peter A.; Fehm, Tanja; Waal, Johann de; Rezai, Mahdi; Baier, Bernd; Baake, Gerold; Kolberg, Hans-Christian; Guggenberger, Martin; Warm, Mathias; Harbeck, Nadia; Wuerstlein, Rachel; Deuker, Joerg-Uwe; Dall, Peter; Richter, Barbara; Wachsmann, Grischa; Brucker, Cosima; Siebers, Jan W.; Fersis, Nikos; Kuhn, Thomas; Wolf, Christopher; Vollert, Hans-Walter; Breitbach, Georg-Peter; Janni, Wolfgang; Landthaler, Robert; Kohls, Andreas; Rezek, Daniela; Noesselt, Thomas; Fischer, Gunnar; Henschen, Stephan; Praetz, Thomas; Heyl, Volker; Kühn, Thorsten; Krauss, Thomas; Thomssen, Christoph; Hohn, Andre; Tesch, Hans; Mundhenke, Christoph; Hein, Alexander; Rauh, Claudia; Bayer, Christian M.; Jacob, Adib; Schmidt, Katja; Belleville, Erik; Hadji, Peymann; Brucker, Sara Y.; Beckmann, Matthias W.; Wallwiener, Diethelm; Kümmel, Sherko und Löhberg, Christian R.
(2016):
Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study.
In: Breast Care, Bd. 11, Nr. 5: S. 315-322
[PDF, 86kB]
Kolben, Thomas; Kolben, Theresa M.; Himsl, Isabelle; Degenhardt, Tom; Engel, Jutta; Wuerstlein, Rachel; Mahner, Sven; Harbeck, Nadia und Kahlert, Steffen
(2016):
Local Resection of Primary Tumor in Upfront Stage IV Breast Cancer.
In: Breast Care, Bd. 11, Nr. 6: S. 411-417
[PDF, 399kB]
Finn, Richard S.; Martin, Miguel; Rugo, Hope S.; Jones, Stephen; Im, Seock-Ah; Gelmon, Karen; Harbeck, Nadia; Lipatov, Oleg N.; Walshe, Janice M.; Moulder, Stacy; Gauthier, Eric; Lu, Dongrui R.; Randolph, Sophia; Diéras, Véronique und Slamon, Dennis J.
(2016):
Palbociclib and Letrozole in Advanced Breast Cancer.
In: New England Journal of Medicine, Bd. 375, Nr. 20: S. 1925-1936
Hermelink, Kerstin; Bühner, Markus und Harbeck, Nadia
(2016):
Physical Activity Associated With Fewer Cancers Response.
In: Jnci-Journal of the National Cancer institute, Bd. 108, Nr. 8, djw049
Verma, Sunil; Bartlett, Cynthia Huang; Schnell, Patrick; DeMichele, Angela M.; Loi, Sherene; Ro, Jungsil; Colleoni, Fmarco; Iwata, Hiroji; Harbeck, Nadia; Cristofanilli, Massimo; Zhang, Ke; Thiele, Alexandra; Turner, Nicholas C. und Rugo, Hope S.
(2016):
Palbociclib in Combination With Fulvestrant in Women With Hormone Receptor-Positive/HER2-Negative Advanced Metastatic Breast Cancer: Detailed Safety Analysis From a Multicenter, Randomized, Placebo-Controlled, Phase III Study (PALOMA-3).
In: Oncologist, Bd. 21, Nr. 10: S. 1165-1175
Schouten, Philip C.; Gluz, Oleg; Harbeck, Nadia; Mohrmann, Svjetlana; Diallo-Danebrock, Raihana; Pelz, Enrico; Kruizinga, Janneke; Velds, Arno; Nieuwland, Marja; Kerkhoven, Ron M.; Liedtke, Cornelia; Frick, Markus; Kates, Ronald; Linn, Sabine C.; Nitz, Ulrike und Marme, Frederik
(2016):
BRCA1-like profile predicts benefit of tandem high dose epirubicin-cyclophospamide-thiotepa in high risk breast cancer patients randomized in the WSG-AM01 trial.
In: International Journal of Cancer, Bd. 139, Nr. 4: S. 882-889
Kolben, Thomas; Hary, Thomas; Holdt, Lesca M.; Schwarz, Theresa M.; Goess, Christine; Wuerstlein, Rachel; Gallwas, Julia; Toth, Bettina; Weissenbacher, Tobias; Jeschke, Udo; Harbeck, Nadia und Ditsch, Nina
(2016):
Thyroid Hormones and Vitamin D in Patients with Breast Cancer with Mutations in BRCA1 or BRCA2 Genes.
In: Anticancer Research, Bd. 36, Nr. 6: S. 3185-3190
Yardley, Denise A.; Brufsky, Adam; Coleman, Robert E.; Conte, Pierfranco F.; Cortes, Javier; Glueck, Stefan; Nabholtz, Jean-Mark A.; O'Shaughnessy, Joyce; Beck, Robert M.; Ko, Amy; Renschler, Markus F.; Barton, Debora und Harbeck, Nadia
(2015):
Phase II/III weekly nab-paclitaxel plus gemcitabine or carboplatin versus gemcitabine/carboplatin as first-line treatment of patients with metastatic triple-negative breast cancer (the tnAcity study): study protocol for a randomized controlled trial.
In: Trials
16:575
[PDF, 1MB]
Gnant, Michael; Thomssen, Christoph und Harbeck, Nadia
(2015):
St. Gallen/Vienna 2015: A Brief Summary of the Consensus Discussion.
In: Breast Care, Bd. 10, Nr. 2: S. 124-130
[PDF, 115kB]
Harbeck, Nadia; Gnant, Michael und Thomssen, Christoph
(2015):
Breast Cancer Is Our Global Responsibility.
In: Breast Care, Bd. 10, Nr. 6: S. 360
[PDF, 64kB]
Jackisch, Christian; Harbeck, Nadia; Huober, Jens; Minckwitz, Gunter von; Gerber, Bernd; Kreipe, Hans-Heinrich; Liedtke, Cornelia; Marschner, Norbert; Möbus, Heike; Scheithauer, Heike; Schneeweiss, Andreas; Thomssen, Christoph; Loibl, Sibylle; Beckmann, Matthias W.; Blohmer, Jens-Uwe; Costa, Serban-Dan; Decker, Thomas; Diel, Ingo; Fasching, Peter A.; Fehm, Tanja; Janni, Wolfgang; Lueck, Hans-Joachim; Maass, Nicolai; Scharl, Anton und Untch, Michael
(2015):
14th St. Gallen International Breast Cancer Conference 2015: Evidence, Controversies, Consensus - Primary Therapy of Early Breast Cancer: Opinions Expressed by German Experts.
In: Breast Care, Bd. 10, Nr. 3: S. 211-219
[PDF, 217kB]
Duffy, Michael J.; McGowan, Patricia M.; Harbeck, Nadia; Thomssen, Christoph und Schmitt, Manfred
(2014):
uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies.
In: Breast Cancer Research
16:428
[PDF, 280kB]
Ataseven, Beyhan; Gunesch, Angela; Eiermann, Wolfgang; Kates, Ronald E.; Högel, Bernhard; Knyazev, Pjotr; Ullrich, Axel und Harbeck, Nadia
(2014):
PTK7 as a potential prognostic and predictive marker of response to adjuvant chemotherapy in breast cancer patients, and resistance to anthracycline drugs.
In: Oncotargets and Therapy, Bd. 7: S. 1723-1731
[PDF, 668kB]
Harbeck, Nadia; Marschner, Norbert; Untch, Michael; Decker, Thomas; Hegewisch-Becker, Susanna; Jackisch, Christian; Huober, Jens; Lück, Hans-Joachim; Minckwitz, Gunter von; Scharl, Anton; Schneeweiss, Andreas; Tesch, Hans; Welt, Anja; Wuerstlein, Rachel und Thomssen, Christoph
(2014):
Second International Consensus Conference on Advanced Breast Cancer (ABC2), Lisbon, 11/09/2013: The German Perspective.
In: Breast Care, Bd. 9, Nr. 1: S. 52-59
[PDF, 164kB]
Loibl, Sibylle; Rokitta, Dennis; Conrad, Bettina; Harbeck, Nadia; Wüllner, Michaela; Warm, Mathias; Schwedler, Kathrin; Gerber, Bernd; Schrader, Iris; Eidtmann, Holger; Mehta, Keyur; Fuhr, Uwe und Minckwitz, Gunter von
(2014):
Sorafenib in the Treatment of Early Breast Cancer: Results of the Neoadjuvant Phase II Study - SOFIA.
In: Breast Care, Bd. 9, Nr. 3: S. 169-174
[PDF, 187kB]
Thomssen, Christoph und Harbeck, Nadia
(2014):
Cutting-edge therapy concepts - cure metastatic breast cancer?
In: Breast Care, Bd. 9, Nr. 1: S. 5-6
[PDF, 55kB]
Richters, Lisa; Ortmann, Monika; Faust, Michael; Kraemer, Stefan; Mallmann, Peter; Harbeck, Nadia und Rhiem, Kerstin
(2013):
The Oncological Emergency Case: Paraneoplastic Hypoglycemia in Metastatic Breast Cancer - Case Report and Brief Review of the Literature.
In: Breast Care, Nr. 5: S. 368-370
[PDF, 252kB]
Untch, Michael; Gerber, Bernd; Harbeck, Nadia; Jackisch, Christian; Marschner, Norbert; Moebus, Volker; Minckwitz, Gunter von; Loibl, Sibylle; Beckmann, Matthias W.; Blohmer, Jens-Uwe; Costa, Serban-Dan; Decker, Thomas; Diel, Ingo; Dimpfl, Thomas; Eiermann, Wolfgang; Fehm, Tanja; Friese, Klaus; Jänicke, Fritz; Janni, Wolfgang; Jonat, Walter; Kiechle, Marion; Köhler, Uwe; Lück, Hans-Joachim; Maass, Nicolai; Possinger, Kurt; Rody, Achim; Scharl, Anton; Schneeweiss, Andreas; Thomssen, Christoph; Wallwiener, Diethelm und Welt, Anja
(2013):
13th St. Gallen International Breast Cancer Conference 2013: Primary Therapy of Early Breast Cancer Evidence, Controversies, Consensus - Opinion of a German Team of Experts (Zurich 2013).
In: Breast Care, Nr. 3: S. 221-229
[PDF, 211kB]
Thomssen, Christoph und Harbeck, Nadia
(2013):
ABC2 Consensus Conference on Advanced Breast Cancer: Brief Summary of the Consensus Panel on Saturday November 9, 2013.
In: Breast Care, Nr. 6: S. 455-456
[PDF, 62kB]
Scharl, Anton; Thomssen, Christoph; Harbeck, Nadia und Müller, Volkmar
(2013):
AGO Recommendations for Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2013.
In: Breast Care, Nr. 3: S. 174-180
[PDF, 687kB]
Fasunla, Ayotunde J.; Harbeck, Nadia; Schmalfeld, Barbara; Berktold, Sabina; Boehner, Christina; Hundt, Walter; Wolf, Petra und Steinbach, Silke
(2013):
Is Routine Audiometric Evaluation Necessary in Gynaecologic Tumour Patients Undergoing Chemotherapy?
In: Breast Care, Nr. 4: S. 276-281
[PDF, 601kB]
Harbeck, Nadia; Beckmann, Matthias W.; Rody, Achim; Schneeweiss, Andreas; Müller, Volkmar; Fehm, Tanja; Marschner, Norbert; Gluz, Oleg; Schrader, Iris; Heinrich, Georg; Untch, Michael und Jackisch, Christian
(2013):
HER2 Dimerization Inhibitor Pertuzumab - Mode of Action and Clinical Data in Breast Cancer.
In: Breast Care, Nr. 1: S. 49-55
[PDF, 954kB]
Gluz, Oleg; Hofmann, Daniel; Würstlein, Rachel; Liedtke, Cornelia; Nitz, Ulrike und Harbeck, Nadia
(2013):
Genomic Profiling in Luminal Breast Cancer.
In: Breast Care, Nr. 6: S. 414-422
[PDF, 261kB]
Harbeck, Nadia; Scharl, Anton; Thomssen, Christoph und Müller, Volkmar
(2013):
AGO Recommendations for Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2013.
In: Breast Care, Nr. 3: S. 181-185
[PDF, 838kB]
Harbeck, Nadia; Blettner, Maria; Hadji, Peyman; Jackisch, Christian; Lueck, Hans-Joachim; Windemuth-Kieselbach, Christine; Zaun, Silke; Haidinger, Renate; Schmitt, Doris; Schulte, Hilde; Nitz, Ulrike und Kreienberg, Rolf
(2013):
Patient’s Anastrozole Compliance to Therapy (PACT) Program: Baseline Data and Patient Characteristics from a Population-Based, Randomized Study Evaluating Compliance to Aromatase Inhibitor Therapy in Postmenopausal Women with Hormone-Sensitive Early Breast Cancer.
In: Breast Care, Nr. 2: S. 110-120
[PDF, 681kB]
Hofmann, Daniel; Nitz, Ulrike; Gluz, Oleg; Kates, Ronald E.; Schinkoethe, Timo; Staib, Peter und Harbeck, Nadia
(2013):
WSG ADAPT - adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: study protocol for a prospective, multi-center, controlled, non-blinded, randomized, investigator initiated phase II/III trial.
In: Trials
14:261
[PDF, 1MB]
Roethlisberger, Maria; Würstlein, Rachel; Majores, Michael; Müller-Stöver, Irene; Seitz, Hanns M.; Rhiem, Kerstin; Kraemer, Stefan; Mallmann, Peter; Büttner, Reinhard und Harbeck, Nadia
(2012):
Filariasis of the Axilla in a Patient Returning from Travel Abroad: A Case Report.
In: Breast Care, Nr. 6: S. 487-489
[PDF, 493kB]
Schönherr, Alexandra; Aivazova-Fuchs, Viktoria; Annecke, Katja; Jückstock, Julia K.; Hepp, Philip; Andergassen, Ulrich; Augustin, Doris; Simon, Wolfgang; Wischnik, Arthur; Mohrmann, Svjetlana; Salmen, Jessica; Zwingers, Thomas; Kiechle, Marion; Harbeck, Nadia; Friese, Klaus; Janni, Wolfgang und Rack, Brigitte
(2012):
Toxicity Analysis in the ADEBAR Trial: Sequential Anthracycline-Taxane Therapy Compared with FEC120 for the Adjuvant Treatment of High-Risk Breast Cancer.
In: Breast Care, Nr. 4: S. 289-295
[PDF, 207kB]
Scharl, Anton; Thomssen, Christoph und Harbeck, Nadia
(2012):
AGO Recommendations for Diagnosis and Treatment of Patients with Early and Metastatic Breast Cancer: Update 2012.
In: Breast Care, Nr. 4: S. 322-335
[PDF, 435kB]
Janni, Wolfgang; Harbeck, Nadia; Huober, Jens; Minckwitz, Gunter von; Möbus, Volker; Müller, Volkmar und Thomssen, Christoph
(2012):
Conclusion from the Annual Meeting of the Society of Clinical Oncology 2012 in Chicago - Expert Opinions Revisited.
In: Breast Care, Nr. 4: S. 336-340
[PDF, 128kB]
Cardoso, Fatima und Harbeck, Nadia
(2012):
Breast Cancer in Young Women - a Clinical Challenge to Be Addressed in a Multidisciplinary Setting.
In: Breast Care, Nr. 3: S. 193-194
[PDF, 97kB]
Thomssen, Christoph; Gnant, Michael und Harbeck, Nadia
(2012):
Current Research of the Pharmaceutical Industry.
In: Breast Care, Nr. 2: S. 155-164
[PDF, 174kB]
Untch, Michael; Gerber, Bernd; Möbus, Volker; Schneeweiss, Andreas; Thomssen, Christoph; Minckwitz, Gunter von; Beckmann, Matthias W.; Blohmer, Jens-Uwe; Costa, Serban-Dan; Diedrich, Klaus; Diel, Ingo; Eiermann, Wolfgang; Friese, Klaus; Harbeck, Nadia; Hilfrich, Jörn; Jackisch, Christian; Janni, Wolfgang; Jänicke, Fritz; Jonat, Walter; Kaufmann, Manfred; Kiechle, Marion; Köhler, Uwe; Kreienberg, Rolf; Maass, Nicolai; Marschner, Norbert; Nitz, Ulrike; Scharl, Anton und Wallwiener, Diethelm
(2011):
Zurich Consensus: Statement of German Experts on St. Gallen Conference 2011 on Primary Breast Cancer (Zurich 2011).
In: Breast Care, Nr. 2: S. 144-152
[PDF, 304kB]
Schneeweiss, Andreas; Bischoff, Joachim; Gerber, Bernd und Harbeck, Nadia
(2011):
Antiangiogenesis in Breast cancer therapy.
In: Breast Care, Nr. 6: S. 485-487
[PDF, 97kB]
Stemmler, Hans-Joachim; Harbeck, Nadia; de Rivera, Isolde Groell; Kaiser, Ursula Vehling; Rauthe, Gerhard; Abenhardt, Wolfgang; Artmann, Almut; Sommer, Harald; Meerpohl, Hans-Gerd; Kiechle, Marion und Heinemann, Volker
(2010):
Prospective Multicenter Randomized Phase III Study of Weekly versus Standard Docetaxel (D2) for First-Line Treatment of Metastatic Breast Cancer.
In: Oncology, Nr. 3-4: S. 197-203
[PDF, 209kB]
Stemmler, Hans-Joachim; Harbeck, Nadia; de Rivera, Isolde Groell; Kaiser, Ursula Vehling; Rauthe, Gerhard; Abenhardt, Wolfgang; Artmann, Almut; Sommer, Harald; Meerpohl, Hans-Gerd; Kiechle, Marion und Heinemann, Volker
(2010):
Prospective Multicenter Randomized Phase III Study of Weekly versus Standard Docetaxel plus Doxorubicin (D4) for First-Line Treatment of Metastatic Breast Cancer.
In: Oncology, Nr. 3-4: S. 204-210
[PDF, 215kB]
Beckmann, Matthias W.; Blohmer, Jens-Uwe; Costa, Serban-Dan; Diedrich, Klaus; Diel, Ingo; Eiermann, Wolfgang; Friese, Klaus; Gerber, Bernd; Harbeck, Nadia; Hilfrich, Joern; Janni, Wolfgang; Jaenicke, Fritz; Jonat, Walter; Kaufmann, Manfred; Kiechle, Marion; Koehler, Uwe; Kreienberg, Rolf; Minckwitz, Gunter von; Moebus, Volker; Nitz, Ulrike; Schneeweiss, Andreas; Thomssen, Christoph und Wallwiener, Diethelm
(2009):
Zurich Consensus: German Expert Opinion on the St. Gallen Votes on 15 March 2009 (11th International Conference at St. Gallen: Primary Therapy of Early Breast Cancer).
In: Breast Care, Nr. 2: S. 109-116
[PDF, 128kB]
Janni, Wolfgang; Rack, Brigitte; Harbeck, Nadia; Bauerfeind, Ingo; Sommer, Harald und Friese, Klaus
(2008):
Node-positive breast cancer: Which are the best chemotherapy regimens?
In: Breast Care, Nr. 4: S. 244-250
[PDF, 935kB]
Harbeck, Nadia; Heinemann, Volker; Loibl, Sibylle und Untch, Michael
(2008):
Clinical experience with lapatinib in patients with ErbB2-overexpressing metastatic breast cancer.
In: Breast Care, Nr. 1: S. 7-12
[PDF, 204kB]
Loibl, Sibylle; Minckwitz, Gunter von; Harbeck, Nadia; Janni, Wolfgang; Elling, Dirk; Kaufmann, Manfred; Eggemann, Holm; Nekljudova, Valentina; Sommer, Harald; Kiechle, Marion und Kuemmel, Sherko
(2008):
Clinical feasibility of (neo)adjuvant taxane-based chemotherapy in older patients: analysis of > 4,500 patients from four German randomized breast cancer trials.
In: Breast Cancer Research
10:R77
[PDF, 838kB]
Harbeck, Nadia; Rack, Brigitte und Janni, Wolfgang
(2007):
ASCO 2007: What remains important for breast cancer systemic therapy in the routine setting?
In: Breast Care, Nr. 4: S. 241-243
[PDF, 54kB]